At a Glance

Overview	Details
Condition	Pancreatitis (inflammation of the pancreas)
Main types	Acute pancreatitis and chronic pancreatitis
Common causes	Gallstones, alcohol consumption, high triglyceride levels and certain medications
Typical symptoms	Upper abdominal pain, pain extending to the back, nausea and vomiting
Emergency warning signs	Sudden severe abdominal pain, persistent vomiting, fainting, breathing difficulties or signs of serious infection
Diagnosis	Clinical assessment, pancreatic enzyme blood tests and imaging when indicated
Treatment	Hospital monitoring, intravenous fluids, pain relief, nutritional support and treatment of the underlying cause
Possible complications	Pancreatic necrosis, infected collections, organ failure and, in chronic disease, digestive problems or diabetes

Pancreatitis is an inflammatory condition affecting the pancreas that can range from a relatively mild illness to a life-threatening medical emergency. It often begins with upper abdominal pain, sometimes accompanied by nausea and vomiting. Although these symptoms can resemble those of other digestive conditions, acute pancreatitis may worsen rapidly and, in severe cases, affect organs beyond the pancreas. 

The causes and consequences of pancreatitis vary. Gallstones and alcohol consumption are among the most common triggers of acute pancreatitis, while other factors, including markedly elevated blood triglycerides, certain medications and abnormalities of the pancreatic or bile ducts, may also contribute. Some patients experience a single episode and recover, whereas others develop recurrent inflammation or chronic pancreatic damage that affects digestion and blood sugar regulation.

n this blog, we discuss what causes pancreatitis, how acute and chronic pancreatitis differ, which symptoms should not be ignored, how the condition is investigated and when pancreatitis requires emergency medical care.

What is Pancreatitis?

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach that performs two essential functions. It produces digestive enzymes that help break down food in the small intestine and releases hormones, including insulin and glucagon, that regulate blood glucose levels.

Under normal circumstances, pancreatic digestive enzymes are produced and transported through the pancreatic duct before becoming fully active in the intestine. In acute pancreatitis, abnormal activation of digestive enzymes within the pancreas and other inflammatory processes can injure pancreatic tissue, producing swelling, pain and inflammation. In severe cases, the inflammatory response can extend beyond the pancreas and affect other organs.

Pancreatitis is broadly classified into two forms:

• Acute pancreatitis — A sudden episode of pancreatic inflammation that develops over hours or days [1]. Many patients recover with appropriate treatment, although some develop serious local or systemic complications.
• Chronic pancreatitis — A long-standing inflammatory condition characterised by progressive structural damage, fibrosis and potentially irreversible loss of pancreatic function [2]. It may cause persistent or recurrent pain, digestive difficulties and diabetes.

The distinction matters because acute pancreatitis requires assessment of the immediate severity and underlying cause, while chronic pancreatitis often involves longer-term management of pain, nutrition, pancreatic function and associated complications.

What Causes Pancreatitis?

Pancreatitis can develop when digestive enzymes and inflammatory processes injure pancreatic tissue. Although gallstones and alcohol are among the leading causes, several other medical conditions and exposures can trigger inflammation. 

• Gallstones — Gallstones are a major cause of acute pancreatitis. A stone passing from the gallbladder into the common bile duct may temporarily obstruct the area where bile and pancreatic secretions drain into the small intestine. This can trigger pancreatic inflammation, even if the stone subsequently passes. Gallstone pancreatitis may occur in someone who has not previously experienced gallbladder symptoms [3].
• Alcohol consumption — Heavy alcohol use is associated with both acute and chronic pancreatitis [4]. The risk generally increases with sustained excessive consumption, although individual susceptibility varies. Alcohol is an important cause to investigate, but pancreatitis should not automatically be attributed to alcohol simply because a patient drinks.
• High triglyceride levels — Markedly elevated triglycerides, a type of fat found in the blood, can trigger acute pancreatitis [5]. This is particularly relevant when levels exceed approximately 1,000 mg/dL (11.3 mmol/L), although the clinical context and other potential causes must also be considered.
• Certain medications — Some medicines have been associated with drug-induced pancreatitis [6]. However, establishing that a medication is responsible can be difficult, and other causes need to be excluded. Patients should not discontinue prescribed treatment without medical advice.
• High blood calcium levels — Hypercalcaemia, particularly when pronounced, can contribute to pancreatic inflammation [7]. It may occur in association with conditions such as hyperparathyroidism.
• Pancreatic duct abnormalities or obstruction — Structural abnormalities, duct narrowing or an obstructing lesion may interfere with pancreatic drainage [8]. In some patients, a pancreatic tumour may be responsible, particularly when pancreatitis develops without an obvious cause in an older adult.
• Medical procedures, injuries and other conditions — Pancreatitis can occasionally follow abdominal trauma or endoscopic retrograde cholangiopancreatography (ERCP), a procedure used to investigate or treat problems involving the bile and pancreatic ducts. Autoimmune conditions, genetic factors and certain infections may also contribute.

In some cases, the cause remains unidentified after initial investigation. This is known as idiopathic pancreatitis. Further assessment may be appropriate, especially when episodes recur, because small gallstones, pancreatic duct abnormalities or other underlying conditions may not be apparent on the first examination.

What are the Warning Signs of Acute Pancreatitis?

The most characteristic symptom of acute pancreatitis is pain in the upper abdomen. It may begin suddenly or develop over several hours and can range from moderate discomfort to severe, persistent pain. The pain frequently extends towards the back and may be accompanied by nausea, vomiting or abdominal tenderness.

Common symptoms include:

• Upper abdominal pain — Often felt in the centre or upper part of the abdomen and may become persistent or severe.
• Pain extending to the back — Some patients experience pain that appears to pass through the upper abdomen towards the back.
• Nausea and vomiting — These frequently accompany an acute episode and may make it difficult to tolerate food or fluids.
• Abdominal tenderness or swelling — The abdomen may become painful to touch or feel distended.
• Fever — An elevated temperature can accompany pancreatic inflammation, although it may also indicate infection or another complication.
• Rapid heartbeat — This may occur in association with pain, dehydration or a more extensive inflammatory response.

The symptoms of acute pancreatitis can overlap with gallbladder inflammation, peptic ulcer disease and other abdominal emergencies. Severe upper abdominal pain may also arise from conditions unrelated to the digestive system, including certain cardiovascular emergencies.

Persistent or severe upper abdominal pain, particularly when accompanied by repeated vomiting, requires urgent medical assessment rather than observation at home.

When Does Pancreatitis Become a Medical Emergency?

Acute pancreatitis can become life-threatening when inflammation extends beyond the pancreas and causes significant fluid loss, circulatory problems or dysfunction of major organs. Although many patients recover without developing severe complications, it is not always possible to determine how serious an episode will become from the initial pain or symptoms alone.

Emergency medical assessment is particularly important when abdominal pain is accompanied by signs that may indicate severe inflammation, dehydration, infection or organ dysfunction.

Warning Signs Requiring Emergency Assessment

• Sudden, severe or rapidly worsening upper abdominal pain
• Repeated vomiting or an inability to keep fluids down
• Fainting, collapse, marked dizziness or confusion
• Shortness of breath or difficulty breathing
• Fever or chills accompanied by severe abdominal pain
• Jaundice, especially when accompanied by fever or chills
• A very rapid heartbeat with significant weakness or signs of dehydration

These symptoms may indicate acute pancreatitis, a serious complication or another abdominal emergency. Patients experiencing them should attend an emergency department promptly. 

How is Mild Pancreatitis Different from Severe Pancreatitis?

The severity of acute pancreatitis is determined by the extent of inflammation, the presence of complications and whether other organs are affected. Pain intensity alone cannot reliably distinguish a mild episode from a severe one.

Severity	Clinical Characteristics
Mild acute pancreatitis	No organ failure or local or systemic complications. Most patients recover with appropriate supportive treatment.
Moderately severe acute pancreatitis	Temporary organ failure lasting no longer than 48 hours, local or systemic complications, or both, without persistent organ failure.
Severe acute pancreatitis	Persistent organ failure lasting more than 48 hours, potentially involving the lungs, kidneys or cardiovascular system.

In severe pancreatitis, the inflammatory response can impair circulation, breathing or kidney function. Some patients also develop pancreatic necrosis, in which part of the pancreatic tissue loses its blood supply and becomes non-viable. Necrosis may remain sterile or become infected, creating additional treatment challenges [9].

The severity of an episode may not be fully apparent at presentation. Patients therefore require appropriate clinical assessment and, when admitted, reassessment during the early course of the illness to identify deterioration or developing complications.

How is Acute Pancreatitis Diagnosed?

Diagnosis begins with an assessment of the patient’s symptoms, medical history and physical examination. Blood tests are used to look for evidence of pancreatic inflammation, while imaging may help establish the underlying cause or identify complications.

Acute pancreatitis is generally diagnosed when at least two of the following three criteria are present:

1. Abdominal pain characteristic of acute pancreatitis.
2. Blood lipase or amylase levels are at least three times the upper limit of normal.
3. Imaging findings consistent with acute pancreatitis.

Blood lipase is commonly used because it is a useful marker of pancreatic injury. However, elevated pancreatic enzymes are not specific to pancreatitis in every circumstance, and the results must be interpreted alongside the clinical findings.

Further investigations may include:

• Blood tests — Liver blood tests may suggest gallstone-related obstruction, while triglyceride and calcium measurements can help identify other causes. Kidney function, blood counts and other tests help assess the patient's overall condition and possible complications.
• Abdominal ultrasound — Ultrasound is particularly useful for identifying gallstones and assessing the gallbladder and bile ducts. It is often performed when acute pancreatitis is diagnosed because gallstones are a common underlying cause.
• Contrast-enhanced CT — CT may be required when the diagnosis is uncertain, the patient is not improving as expected or complications are suspected. Routine CT is not necessary immediately for every patient with an otherwise clear diagnosis.
• MRI and magnetic resonance cholangiopancreatography (MRCP) — These examinations may help assess the pancreatic and bile ducts, particularly when a retained bile duct stone or structural abnormality is suspected.
• Endoscopic ultrasound (EUS) — EUS may be considered when further investigation is needed, particularly in patients with recurrent or unexplained pancreatitis.

The investigations are selected according to the clinical presentation. Their purpose is not only to confirm pancreatitis but also to establish its cause and determine whether complications or additional treatment are likely.

How is Acute Pancreatitis Treated in the Hospital?

Treatment of acute pancreatitis focuses on supporting the patient while the inflammation settles, identifying the underlying cause and managing any complications. The approach depends on the severity of the episode and the patient's response to initial treatment.

• Intravenous fluid replacement — Pancreatic inflammation can cause substantial fluid shifts and dehydration. Intravenous fluids help maintain circulation and organ perfusion, particularly during the early stages [10]. The amount given must be reassessed regularly because excessive fluid administration can also cause harm, especially in patients with heart or kidney conditions.
• Pain relief and symptom control — Appropriate pain medication is important because pancreatic inflammation can cause considerable discomfort. Treatment may also include medication for nausea and vomiting.
• Nutritional support — Patients with mild acute pancreatitis are generally encouraged to resume oral feeding early, as tolerated, rather than remaining without food for a prolonged period. When oral intake is not possible, particularly in more severe cases, nutritional support through the digestive tract may be required.
• Monitoring for complications — Clinical observations, blood tests and further imaging when indicated help identify dehydration, organ dysfunction, pancreatic necrosis or other complications. Patients with severe disease may require intensive care.
• Treatment of the underlying cause — Management may include removing the gallbladder after gallstone pancreatitis, addressing a retained bile duct stone or treating severe hypertriglyceridaemia.

Antibiotics are not routinely prescribed simply because the pancreas is inflamed. They are used when there is an established or strongly suspected infection, such as infected pancreatic necrosis or associated cholangitis.

Most patients do not require pancreatic surgery during an uncomplicated acute episode. Procedures become relevant when there is a specific cause requiring intervention or when complications develop.

Why is Treating Gallstones Important After Gallstone Pancreatitis?

When pancreatitis is caused by gallstones, treating the acute inflammation is only part of the management. If the gallbladder remains in place, further stones may pass into the bile duct and trigger another episode.

For patients with mild gallstone pancreatitis who are suitable for surgery, laparoscopic cholecystectomy or keyhole gallbladder removal, is generally recommended during the same hospital admission, preferably before discharge. This reduces the risk of recurrent gallstone-related complications.

The timing may differ in patients with severe pancreatitis, pancreatic necrosis or significant fluid collections. In these circumstances, surgery may need to be delayed until the patient's condition and local inflammation have improved.

Some patients also require endoscopic retrograde cholangiopancreatography (ERCP). This procedure can be used to remove a stone obstructing the common bile duct or to relieve biliary obstruction. Urgent ERCP is particularly important when acute pancreatitis is accompanied by cholangitis, a potentially serious infection of the bile ducts.

What Complications Can Develop from Acute Pancreatitis?

Most patients with mild acute pancreatitis recover without lasting complications. However, severe inflammation can damage pancreatic tissue, affect surrounding structures or cause problems elsewhere in the body.

Important complications include:

• Pancreatic necrosis — Severe inflammation may result in areas of pancreatic or surrounding tissue becoming non-viable. Necrosis can remain sterile or become infected. Infected necrosis is a serious complication that may require antibiotics and, in selected cases, drainage or removal of dead tissue.
• Pancreatic fluid collections — Inflammatory fluid may accumulate within or around the pancreas. Some collections resolve spontaneously, while others persist or become symptomatic.
• Pancreatic pseudocysts — A pseudocyst is a mature, encapsulated fluid collection that may develop after pancreatitis. Many do not require intervention, but treatment may be considered if a pseudocyst causes persistent symptoms, obstruction, infection or other complications.
• Walled-off necrosis — This is an encapsulated collection containing necrotic pancreatic or surrounding tissue that typically develops several weeks after necrotising pancreatitis [11]. Its management differs from that of a simple pancreatic pseudocyst.
• Infection — Infection of necrotic tissue or other associated collections may cause clinical deterioration and require specialist treatment.
• Organ failure — Severe pancreatitis can impair lung, kidney or cardiovascular function. Persistent organ failure is the defining feature of severe acute pancreatitis and may require intensive care.

Not every collection or area of necrosis needs immediate drainage or surgery. In clinically stable patients, intervention for necrotic collections is often delayed, where possible, until the collection has matured and treatment can be performed more safely. The decision depends on infection, symptoms, obstruction and the patient’s overall condition.

What is Chronic Pancreatitis and How Does It Differ from Acute Pancreatitis?

Chronic pancreatitis is a long-standing inflammatory condition in which repeated or persistent injury leads to structural changes and fibrosis within the pancreas. Unlike a single episode of acute pancreatitis, chronic disease can progressively impair the organ’s ability to produce digestive enzymes and regulate blood glucose.

Some patients develop chronic pancreatitis following recurrent acute episodes, while others develop it through a combination of genetic, environmental, metabolic or autoimmune factors. Alcohol consumption and smoking are important modifiable risk factors, but chronic pancreatitis can also occur in people who do not drink alcohol.

Symptoms may include:

• Recurrent or persistent upper abdominal pain, sometimes extending to the back
• Pain that becomes worse after eating in some patients
• Unintentional weight loss
• Greasy, bulky or difficult-to-flush stools caused by fat malabsorption
• Diarrhoea or other digestive difficulties
• Diabetes resulting from reduced pancreatic hormone production

The digestive problems associated with chronic pancreatitis often develop when the pancreas can no longer produce sufficient digestive enzymes, a condition known as pancreatic exocrine insufficiency. Patients may require pancreatic enzyme replacement therapy to improve nutrient absorption, alongside dietary assessment and monitoring for nutritional deficiencies.

Chronic pancreatitis also increases the risk of pancreatic cancer, although most people with chronic pancreatitis do not develop it. New or changing symptoms, including unexplained weight loss, jaundice or a significant alteration in pain, should therefore be assessed rather than automatically attributed to the existing condition.

Can Pancreatitis Happen Again After Recovery?

Yes. Some people experience recurrent acute pancreatitis, particularly when the underlying cause has not been addressed. For example, untreated gallstones may trigger another episode, while continued heavy alcohol consumption or persistently elevated triglycerides can contribute to further pancreatic injury.

Preventing recurrence depends on identifying the cause and addressing any modifiable risk factors.

• Treating gallstones — Gallbladder removal is commonly recommended after mild gallstone pancreatitis when the patient is suitable for surgery.
• Avoiding alcohol — Abstinence is particularly important when pancreatitis is alcohol-related and is generally advised following an episode.
• Stopping smoking — Smoking is associated with chronic pancreatic damage and may contribute to disease progression.
• Managing triglycerides — Patients with severe hypertriglyceridaemia may require dietary changes, treatment of associated conditions and lipid-lowering medication.
• Reviewing medications — When drug-induced pancreatitis is suspected, a clinician may assess whether an alternative treatment is appropriate.
• Investigating unexplained episodes — Recurrent pancreatitis without an established cause may warrant additional imaging or specialist assessment.

An isolated episode does not necessarily lead to permanent pancreatic damage. However, recurrent attacks can increase the likelihood of chronic pancreatitis, making investigation and prevention important after recovery.

When Should You See a Pancreatic Specialist?

An acute episode of suspected pancreatitis requires prompt medical assessment, usually in a hospital setting. Specialist review becomes particularly relevant when the underlying cause is uncertain, episodes recur or complications require further investigation or intervention.

A hepatopancreatobiliary (HPB) specialist’s opinion may be appropriate when:

• Pancreatitis is caused by gallstones and gallbladder surgery is being considered
• There are recurrent episodes without a clearly identified cause
• Imaging shows pancreatic necrosis, pseudocysts or other collections
• A pancreatic or bile duct obstruction is suspected
• Symptoms persist after the acute episode has resolved
• Chronic pancreatitis is associated with significant pain or complications
• A pancreatic lesion or other structural abnormality requires further assessment
• Endoscopic, radiological or surgical treatment may be necessary

The purpose of specialist assessment is to determine whether further investigation or intervention is required. Not every patient with pancreatitis needs surgery, and many recover with supportive treatment and appropriate management of the underlying cause.

Key Takeaway

Pancreatitis can range from a short-lived inflammatory episode to a severe illness involving pancreatic tissue damage and organ failure. Gallstones and alcohol are among the leading causes, although metabolic conditions, medications, pancreatic duct abnormalities and other factors may also contribute. 

The most characteristic symptom is upper abdominal pain that may extend towards the back, often accompanied by nausea or vomiting. Acute pancreatitis requires prompt medical assessment, and sudden severe pain, persistent vomiting, breathing difficulties, fainting, confusion or jaundice accompanied by fever should never be ignored. 

Hospital treatment focuses on fluid replacement, pain control, nutritional support, monitoring for complications and addressing the underlying cause. In gallstone pancreatitis, gallbladder removal or selected bile duct procedures may be necessary to reduce the risk of recurrence.

If you have experienced pancreatitis, recurrent upper abdominal pain or complications involving the pancreas or bile ducts, schedule a consultation with a specialist at Tan Siong San Surgery to assess the underlying cause and determine whether further investigation or treatment is appropriate. 

Frequently Asked Questions (FAQs)

References

1. Acute pancreatitis—Causes—Investigations—Management. TeachMeSurgery. Retrieved October 21, 2026, from https://teachmesurgery.com/hpb/pancreas/acute-pancreatitis/ 
2. Sun, L., Jiang, M., Wang, X., Sun, Y., Tu, Y., Li, Z., Peng, L., & Huang, H. (n.d.). Etiology, diagnosis, and management of chronic pancreatitis associated primary complications: A narrative review. Frontiers in Medicine, 13, 1822750. https://doi.org/10.3389/fmed.2026.1822750 
3. Kundumadam, S., Fogel, E. L., & Gromski, M. A. (2021). Gallstone pancreatitis: General clinical approach and the role of endoscopic retrograde cholangiopancreatography. The Korean Journal of Internal Medicine, 36(1), 25–31. https://doi.org/10.3904/kjim.2020.537 
4. Chowdhury, P., & Gupta, P. (2006). Pathophysiology of alcoholic pancreatitis: An overview. World Journal of Gastroenterology : WJG, 12(46), 7421–7427. https://doi.org/10.3748/wjg.v12.i46.7421 
5. Fogacci, F., & Cicero, A. F. G. (2026). Hypertriglyceridaemia-associated acute pancreatitis: Risk stratification, drivers, and prevention of recurrence. Diseases, 14(2), 47. https://doi.org/10.3390/diseases14020047 
6. Jones, M. R., Hall, O. M., Kaye, A. M., & Kaye, A. D. (2015). Drug-induced acute pancreatitis: A review. The Ochsner Journal, 15(1), 45–51. https://pmc.ncbi.nlm.nih.gov/articles/PMC4365846/ 
7. Gieszinger, G., Kui, B., Hegyi, P., Hegyi, P. J., Vincze, Á., Erőss, B., Szentesi, A., Vass, V., Abonyi-Tóth, Z., Izbéki, F., Illés, A., Szabó, I., Czimmer, J., Németh, B. C., Gajdán, L., Papp, M., Hamvas, J., & Czakó, L. (2025). Hypercalcemia causes more severe acute pancreatitis: An international multicenter cohort study. Journal of Clinical Medicine, 14(17), 6304. https://doi.org/10.3390/jcm14176304 
8. Dawod, E., & Kahaleh, M. (2018). Management of benign and malignant pancreatic duct strictures. Clinical Endoscopy, 51(2), 156–160. https://doi.org/10.5946/ce.2017.085 
9. Rashid, M. U., Hussain, I., Jehanzeb, S., Ullah, W., Ali, S., Jain, A. G., Khetpal, N., & Ahmad, S. (2019). Pancreatic necrosis: Complications and changing trend of treatment. World Journal of Gastrointestinal Surgery, 11(4), 198–217. https://doi.org/10.4240/wjgs.v11.i4.198 
10. Yaowmaneerat, T., & Sirinawasatien, A. (2023). Update on the strategy for intravenous fluid treatment in acute pancreatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics, 14(3), 22–32. https://doi.org/10.4292/wjgpt.v14.i3.22 
11. Stamatakos, M., Stefanaki, C., Kontzoglou, K., Stergiopoulos, S., Giannopoulos, G., & Safioleas, M. (2010). Walled-off pancreatic necrosis. World Journal of Gastroenterology : WJG, 16(14), 1707–1712. https://doi.org/10.3748/wjg.v16.i14.1707 

Overview	Details
Condition	Pancreatic cysts
How are they discovered	Often incidentally during an ultrasound, CT scan or MRI performed for another condition
Are they cancerous?	Many are benign, but certain cyst types can develop into cancer
What determines the risk?	Cyst type, size, imaging characteristics, growth, symptoms and other clinical findings
Further assessment	MRI with magnetic resonance cholangiopancreatography (MRCP), CT or endoscopic ultrasound (EUS), depending on the findings
Is regular surveillance necessary?	Some cysts require periodic imaging, while others may not need routine follow-up
When treatment may be considered	When the cyst has concerning features, causes significant symptoms or is associated with suspected or confirmed malignancy

An unexpected finding of a pancreatic cyst during an abdominal scan can raise immediate concerns, particularly because of the association between pancreatic disease and cancer. Yet pancreatic cysts are not all alike. Many are discovered in people who have no pancreatic symptoms, and some are benign lesions that may never cause problems. Others, however, have the potential to develop into pancreatic cancer. 

The difficulty is that a pancreatic cyst cannot be assessed by its presence or size alone. Its internal structure, relationship with the pancreatic duct, changes over time and any associated symptoms can provide important clues about its nature. A small cyst may require further investigation if it has suspicious features, while another cyst may be suitable for surveillance without immediate intervention. 

Understanding the type of pancreatic cyst is therefore the starting point for deciding what happens next. In this blog, we explain why pancreatic cysts are found incidentally, how benign and potentially precancerous cysts differ, which findings warrant closer attention and when surveillance, further investigation or specialist treatment may be appropriate.

What Exactly is a Pancreatic Cyst?

A pancreatic cyst is a fluid-containing lesion that develops within or around the pancreas, an organ located behind the stomach that produces digestive enzymes and hormones involved in regulating blood sugar. Pancreatic cysts encompass several different conditions, ranging from benign fluid collections to cystic tumours with varying degrees of malignant potential.

Many pancreatic cysts are detected incidentally during CT or MRI examinations performed for unrelated abdominal symptoms or other medical conditions. Improved imaging technology has made it increasingly common to identify small cysts that might otherwise have remained undetected.

Not every pancreatic cyst requires treatment, but identifying its type is important because the approach to management differs considerably. Some cysts have characteristic imaging features that support a benign diagnosis, while others require closer examination of their internal structure and relationship with the pancreatic duct.

Why are Pancreatic Cysts Often Found Incidentally?

Many pancreatic cysts develop without causing pain, digestive difficulties or other noticeable symptoms. Small cysts may not interfere with the pancreatic duct or surrounding structures, allowing them to remain undetected for years.

They are frequently discovered during imaging undertaken for another reason, such as investigating abdominal discomfort, examining the liver or gallbladder, or assessing an unrelated medical condition. The finding may appear in a radiology report even when there was no previous suspicion of pancreatic disease.

The increased detection of incidental pancreatic cysts does not mean that all such lesions are dangerous. It does, however, create an important clinical question: does the cyst have features consistent with a benign lesion, or does it belong to a category that requires surveillance or further investigation?

The answer depends on the cyst’s characteristics and the patient’s wider clinical circumstances, rather than simply on the fact that it was discovered unexpectedly.

What are the Different Types of Pancreatic Cysts?

Pancreatic cysts are not a single disease. Different types have distinct causes, imaging appearances and implications for treatment or follow-up. Establishing which type is present helps determine whether the cyst can be left alone, requires ongoing surveillance or needs further assessment.

• Serous cystic neoplasms (SCNs) — These are generally benign pancreatic cystic tumours with a very low risk of malignant transformation [1]. They often contain multiple small fluid-filled spaces and may have a characteristic appearance on imaging. When the diagnosis is confident and the lesion is not causing symptoms, surgery is usually unnecessary.
• Intraductal papillary mucinous neoplasms (IPMNs) — These are mucin-producing cystic tumours arising from the pancreatic duct system [2]. They may involve the main pancreatic duct, its side branches or both. IPMNs are important because some can progress to high-grade dysplasia or invasive cancer. Their risk varies according to the type of IPMN and the presence of concerning imaging or clinical features.
• Mucinous cystic neoplasms (MCNs) — These are mucin-producing cystic tumours that occur predominantly in women and are usually located in the body or tail of the pancreas [3]. Unlike IPMNs, they generally do not communicate with the pancreatic duct. MCNs have malignant potential, although not every lesion contains or will develop cancer.
• Pancreatic pseudocysts — These are fluid collections that typically develop following acute pancreatitis, chronic pancreatitis or pancreatic injury [4]. They are not true cystic neoplasms and do not have the same precancerous potential as mucinous cystic tumours. Their management depends on factors such as symptoms, infection, obstruction and other complications.
• Other pancreatic cystic lesions — Less common conditions include solid pseudopapillary neoplasms, cystic neuroendocrine tumours and other unusual pancreatic lesions. Some require specialist investigation because their behaviour and treatment differ from those of more common pancreatic cysts.

These distinctions are particularly important because the term “pancreatic cyst” does not indicate whether a lesion is benign, precancerous or malignant. Further imaging or specialist assessment may be needed when its nature cannot be established confidently from the initial scan.

Can an Incidental Pancreatic Cyst Be Cancerous?

Yes, certain pancreatic cysts can contain cancer or develop malignant changes over time, but this does not mean that an incidental cyst should be assumed to be cancerous. Many pancreatic cysts are benign, and even among cyst types with malignant potential, progression to cancer is not inevitable. 

The principal concern is identifying the smaller group of lesions that may already contain advanced abnormal cells or have characteristics associated with a higher risk of progression. Mucin-producing cysts, particularly IPMNs and MCNs, receive closer attention because of their potential to develop into cancer [5]. A small branch-duct IPMN without concerning features may be managed through imaging surveillance, whereas a lesion with an enhancing solid component or significant pancreatic duct dilatation may require more urgent specialist evaluation.

The aim of assessment is therefore to identify potentially dangerous cysts without exposing patients with low-risk lesions to unnecessary pancreatic surgery. This distinction is especially important because pancreatic surgery is a major procedure with potential complications, and its benefits must be weighed against the estimated risk associated with the cyst. 

Which Pancreatic Cyst Features Require Closer Attention?

The imaging characteristics of a pancreatic cyst are central to assessing its potential risk. Certain findings can suggest a greater likelihood of advanced cellular changes or malignancy, particularly in mucin-producing cysts. These features are assessed alongside the patient's symptoms, medical history and changes observed on previous scans.

Features that may warrant further investigation include:

• A solid component or mural nodule — A growth projecting from the cyst wall, particularly one that enhances after contrast administration, can be an important warning feature.
• Dilatation of the main pancreatic duct — Enlargement of the duct may indicate involvement of the duct system and can increase concern in certain cyst types.
• Thickened or enhancing cyst walls — These may require closer evaluation, particularly when accompanied by other atypical findings.
• Increasing cyst size or significant growth — Larger cysts and those growing relatively quickly may warrant additional assessment, although growth alone does not establish malignancy.
• Jaundice associated with a pancreatic head cyst — Yellowing of the skin or eyes caused by obstruction of the bile duct is a particularly concerning finding.
• Pancreatitis associated with the cyst — An episode of pancreatic inflammation potentially caused by the lesion may influence the need for further investigation.
• New-onset or worsening diabetes — In the context of a pancreatic cyst, an unexplained change in blood sugar control may be relevant to risk assessment.
• Elevated carbohydrate antigen 19-9 (CA 19-9) — This blood marker may provide additional information, although it cannot diagnose pancreatic cancer on its own.

These findings do not all carry the same level of risk. The 2024 International Evidence-Based Kyoto Guidelines distinguish between worrisome features, which generally prompt closer investigation, and high-risk stigmata, which may indicate a stronger need to consider surgery. Their interpretation is particularly relevant to IPMNs and should not be applied indiscriminately to every type of pancreatic cyst [6]. 

Does the Size of a Pancreatic Cyst Determine Whether It is Dangerous?

Cyst size is an important part of pancreatic cyst assessment, but it cannot establish whether a lesion is benign or malignant on its own. A relatively large cyst with characteristic features of a serous cystic neoplasm may be benign, while a smaller mucin-producing cyst with an enhancing mural nodule may require more detailed investigation.

Rather than relying on a single measurement, doctors consider several questions:

• What type of pancreatic cyst is most likely?
• Does the cyst contain a mural nodule or solid component?
• Is the main pancreatic duct enlarged?
• Has the cyst increased in size since previous imaging?
• Are there symptoms such as jaundice, pancreatitis or unexplained weight loss?
• Does the cyst have other features associated with a higher risk of malignancy?

For IPMNs, a cyst measuring 3 cm or more is generally considered a worrisome feature under the 2024 Kyoto guidelines, but this threshold is not, by itself, an indication for surgery [7]. Other findings, the patient’s overall health and the potential benefits and risks of intervention remain essential considerations.

The significance of cyst size therefore depends on the type of lesion and the other findings present. A larger measurement may justify closer assessment without necessarily making surgical removal the appropriate next step. 

Can a Pancreatic Cyst Cause Symptoms?

Many pancreatic cysts cause no symptoms and are discovered only because imaging was performed for another reason. Symptoms are more likely when a cyst becomes sufficiently large to affect nearby structures, obstructs pancreatic or bile drainage or is associated with inflammation or another complication.

Possible symptoms include:

• Persistent or recurrent upper abdominal pain
• Pain extending towards the back
• Nausea or vomiting
• Feeling full after eating relatively small amounts
• Jaundice, particularly if bile drainage is obstructed
• Episodes of pancreatitis
• Unexplained weight loss or loss of appetite

These symptoms are not specific to pancreatic cysts. Gallbladder disorders, stomach conditions, pancreatitis and other abdominal diseases can produce similar complaints. The presence of a pancreatic cyst on imaging therefore does not establish that it is responsible for a patient’s symptoms.

When symptoms are present, further assessment may be needed to determine whether the cyst’s size, location and imaging features provide a plausible explanation or whether another condition should be investigated.

How are Pancreatic Cysts Diagnosed and Assessed?

Pancreatic cysts are commonly identified on CT or MRI performed for another medical reason. Once a cyst is detected, the next step is to establish its likely type, assess features associated with malignancy and determine whether additional investigation or surveillance is appropriate.

Assessment may involve:

• MRI with magnetic resonance cholangiopancreatography (MRCP) — MRI provides detailed images of the pancreas and cyst contents, while MRCP helps assess the pancreatic duct system and whether a cyst communicates with it. MRI/MRCP is often preferred for characterising and monitoring pancreatic cysts because it avoids ionising radiation.
• Contrast-enhanced CT — CT can help assess the cyst, surrounding pancreatic tissue and associated abnormalities. It may be particularly useful when further anatomical detail is required or when a suspicious lesion needs more extensive evaluation.
• Endoscopic ultrasound (EUS) — This examination involves passing a flexible endoscope through the mouth into the stomach and duodenum. An ultrasound probe at its tip provides detailed images of the pancreas from close range, allowing smaller structures, mural nodules and other features to be assessed more closely.
• EUS-guided fluid sampling — In selected cases, fluid may be collected from the cyst using a fine needle under endoscopic ultrasound guidance. The sample can be assessed for biochemical markers, cytology or molecular findings that may help clarify the cyst type or identify concerning changes. Sampling is not necessary for every cyst and is generally considered when the results could influence management.
• Blood tests and clinical assessment — Relevant investigations may include blood glucose measurements, liver blood tests or CA 19-9 in appropriate circumstances. These findings support the overall assessment but cannot reliably determine whether a cyst is cancerous in isolation.

A clearly characterised, low-risk cyst may not require all these investigations. More detailed assessment is generally reserved for lesions whose nature remains uncertain or whose imaging or clinical features raise concern. 

When Does a Pancreatic Cyst Need a Specialist’s Opinion?

Not every pancreatic cyst requires surgery or extensive investigation. However, specialist assessment becomes important when the initial imaging does not establish the cyst type, when concerning features are present or when a decision is needed about surveillance or treatment.

A specialist opinion may be appropriate when:

• The cyst contains a mural nodule, solid component or other suspicious imaging features
• The main pancreatic duct is dilated
• The cyst has increased significantly in size
• The diagnosis remains uncertain after initial imaging
• The patient develops jaundice or pancreatitis potentially related to the cyst
• There is unexplained weight loss or new-onset diabetes alongside the cyst
• A mucinous cystic neoplasm or IPMN with concerning features is suspected
• The cyst may require ongoing surveillance or surgical treatment

The purpose of specialist assessment is not necessarily to recommend removal. In many cases, it is to establish the likely diagnosis, determine the level of risk and decide whether observation, further imaging, endoscopic assessment or treatment is appropriate.

A hepatopancreatobiliary (HPB) specialist can review the imaging findings alongside the patient’s medical history and overall health, particularly when the potential benefits of intervention need to be weighed against the risks of pancreatic surgery.

Do Pancreatic Cysts Require Regular Follow-Up Scans?

Some pancreatic cysts require surveillance because their appearance may change over time or because they belong to a category with malignant potential. However, routine follow-up is not necessary for every pancreatic cyst, and the appropriate schedule depends on the type of lesion, its characteristics and the patient's circumstances.

For example, a confidently diagnosed asymptomatic serous cystic neoplasm may not require long-term routine imaging. In contrast, many branch-duct IPMNs without high-risk features are monitored using MRI or other appropriate imaging to identify changes that could influence management.

The surveillance plan may take into account:

• Cyst type — Mucin-producing cysts generally require different consideration from clearly benign lesions.
• Cyst size — Size can influence surveillance intervals, particularly for branch-duct IPMNs.
• Imaging characteristics — Nodules, pancreatic duct changes or other concerning findings may justify closer monitoring.
• Changes over time — Growth or the development of new features may lead to additional investigation.
• Age and overall health — Surveillance is most useful when detecting a concerning change could lead to treatment that the patient is fit and willing to undergo.
• Previous investigations — Earlier scans and specialist findings can help establish an appropriate monitoring schedule.

There is no single surveillance interval suitable for every pancreatic cyst. Published guidelines also differ in their recommendations about how frequently certain cysts should be monitored and when surveillance may be discontinued.

Patients should therefore follow an individualised plan rather than assume that every incidental pancreatic cyst requires annual imaging or that surveillance can safely stop after a fixed number of normal examinations. 

What Happens if a Pancreatic Cyst Changes During Surveillance?

Changes detected during surveillance do not necessarily mean that a cyst has become cancerous. Some pancreatic cysts grow slowly over time without developing malignant features. However, a significant change in size, the appearance of a new mural nodule or increasing pancreatic duct dilatation may alter the estimated risk and require further assessment.

When a change is identified, the treating specialist may recommend a shorter interval before the next scan, more detailed imaging or endoscopic ultrasound. In selected cases, EUS-guided sampling may help clarify whether the cyst has developed concerning characteristics.

The decision depends on the nature of the change rather than growth alone. A small increase in size without other suspicious findings may be managed differently from a cyst that develops an enhancing solid component or causes obstructive jaundice.

Surveillance is therefore an active process of reassessment. Its purpose is to identify meaningful changes that could influence treatment decisions while avoiding unnecessary intervention for cysts that remain low risk.

When is Surgery Considered for a Pancreatic Cyst?

Most incidentally detected pancreatic cysts do not require immediate surgery. Surgical treatment is generally considered when a lesion has features associated with a substantial risk of malignancy, when cancer is suspected or confirmed, or when certain cysts cause significant symptoms or complications.

The decision depends on several factors, including the likely cyst type, the presence of high-risk findings, its location within the pancreas and the patient's suitability for surgery.

Possible procedures include:

• Distal pancreatectomy — This involves removing the body or tail of the pancreas and may be considered for selected cystic neoplasms located in these regions. Depending on the condition, the spleen may also need to be removed.
• Pancreaticoduodenectomy (Whipple procedure) — This is a major operation that may be necessary for selected concerning or malignant lesions involving the head of the pancreas. It involves removing the pancreatic head and other associated structures, followed by surgical reconstruction.
• Other pancreatic resections — In carefully selected circumstances, a different procedure may be appropriate depending on the location and nature of the lesion.

Pancreatic surgery carries important risks, including pancreatic leakage, infection, bleeding and potential long-term effects on digestion or blood sugar regulation. These considerations are particularly relevant when the cyst has a low estimated risk of malignant progression.

For this reason, surgery is not recommended solely because a pancreatic cyst has been detected. The decision should follow an assessment of the likely benefits of removing the lesion against the risks of the proposed operation, ideally involving an experienced pancreatic multidisciplinary team. 

Key Takeaway

An incidental pancreatic cyst is not necessarily a sign of cancer, and many lesions can be managed without surgery. However, pancreatic cysts differ substantially in their behaviour. While some are benign, others, particularly certain mucin-producing cysts, have the potential to develop malignant changes. 

Management depends on more than cyst size. Features such as mural nodules, pancreatic duct dilatation, significant growth, jaundice or other concerning clinical findings may warrant additional assessment. Some cysts require regular imaging surveillance, while others may need little or no follow-up once their benign nature has been confidently established. Surgery is generally reserved for selected lesions where the expected benefits justify the risks of pancreatic intervention.

If a pancreatic cyst has been identified on your scan, schedule a consultation with a specialist at Tan Siong San Surgery to review the findings and determine whether further investigation, surveillance or treatment is appropriate.

Frequently Asked Questions (FAQs)

References

1. Hu, F., Hu, Y., Wang, D., Ma, X., Yue, Y., Tang, W., Liu, W., Wu, P., Peng, W., & Tong, T. (2022). Cystic neoplasms of the pancreas: Differential diagnosis and radiology correlation. Frontiers in Oncology, 12, 860740. https://doi.org/10.3389/fonc.2022.860740 
2. Paramythiotis, D., Karlafti, E., Fotiadou, G., Charalampidou, M., Karakatsanis, A., Ioannidis, A., & Michalopoulos, A. (2023). Pancreatic intraductal papillary mucinous neoplasms: A narrative review. Acta Medica Lituanica, 30(1), 53–65. https://doi.org/10.15388/Amed.2023.30.1.6 
3. Ikuta, S., Aihara, T., Yasui, C., Iida, H., Yanagi, H., Mitsunobu, M., Kakuno, A., & Yamanaka, N. (2008). Large mucinous cystic neoplasm of the pancreas associated with pregnancy. World Journal of Gastroenterology : WJG, 14(47), 7252–7255. https://doi.org/10.3748/wjg.14.7252 
4. Pan, G., Wan, M. H., Xie, K.-L., Li, W., Hu, W.-M., Liu, X.-B., Tang, W.-F., & Wu, H. (2015). Classification and management of pancreatic pseudocysts. Medicine, 94(24), e960. https://doi.org/10.1097/MD.0000000000000960 
5. Kruse, D. E., & Paulson, E. K. (2024). The incidental pancreatic cyst: When to worry about cancer. Korean Journal of Radiology, 25(6), 559–564. https://doi.org/10.3348/kjr.2024.0085 
6. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. https://pubmed.ncbi.nlm.nih.gov/38182527/ 
7. Danti, G., Scalzone, L., Mattolini, L., Anichini, M., Treballi, F., Calistri, L., Cozzi, D., & Miele, V. (2026). Pancreatic cystic lesions: From basic knowledge to recent guidelines. Journal of Clinical Medicine, 15(2), 585. https://doi.org/10.3390/jcm15020585 

At a Glance

Overview	Details
Who Needs Surveillance?	People with cirrhosis are an important group for whom hepatocellular carcinoma (HCC) surveillance is recommended.
Why Surveillance Is Needed	HCC can develop without causing noticeable symptoms, particularly in its earlier stages.
Main Surveillance Tests	Liver ultrasound, commonly combined with a blood test for alpha-fetoprotein (AFP).
How Often?	Surveillance is generally performed every 6 months in patients for whom it is indicated.
Does Feeling Well Mean the Risk Is Low?	No. The absence of symptoms does not reliably exclude early HCC.
What if Ultrasound Is Inadequate or Abnormal?	Additional imaging, such as contrast-enhanced CT or MRI, may be required depending on the findings.
Why Early Detection Matters	Detecting HCC at an earlier stage can increase the range of potentially curative treatment options.
Is Surveillance the Same for Everyone?	No. Individual risk, liver function, underlying liver disease and suitability for treatment are considered when planning surveillance.

Cirrhosis does more than affect how well the liver functions. The long-term scarring and regeneration of liver tissue also increase the risk of hepatocellular carcinoma (HCC), the most common type of primary liver cancer. Importantly, this risk is not always accompanied by warning signs. A person may feel well and have no new symptoms while an early liver tumour is developing.

This is why liver cancer surveillance forms an important part of ongoing care for people with cirrhosis who meet surveillance criteria. Early HCC may cause no pain, jaundice, loss of appetite or unexplained weight loss, making symptoms an unreliable way to detect the disease at an early stage. Regular surveillance aims to identify suspicious changes before symptoms develop, when the cancer may be smaller and a wider range of treatment options may still be available.

Surveillance does not mean that everyone with cirrhosis will develop liver cancer. Rather, it provides a structured way of monitoring people at increased risk so that HCC can be detected as early as possible. In this blog, we explain why cirrhosis increases liver cancer risk, how surveillance is performed, what happens when an abnormality is detected and why regular screening remains important even when you feel well.

Why Does Cirrhosis Increase the Risk of Liver Cancer?

Cirrhosis is the advanced stage of scarring that can develop after prolonged liver injury. Healthy liver tissue is progressively replaced by fibrosis and regenerative nodules, which alters the normal structure of the liver. Cirrhosis can result from several underlying liver diseases, including chronic viral hepatitis, alcohol-related liver disease and metabolic liver disease.

The same long-standing processes of liver-cell injury, inflammation and regeneration that contribute to cirrhosis can also create conditions in which abnormal liver cells develop and multiply [1]. As a result, cirrhosis is one of the major risk factors for hepatocellular carcinoma. Importantly, this increased cancer risk can remain even when the underlying liver disease has been treated or brought under better control.

Having cirrhosis does not mean that liver cancer is inevitable. It means that the risk is sufficiently increased in appropriate patients for regular surveillance to become part of long-term liver care. This is fundamentally different from investigating a patient only after symptoms have developed. 

Why Can Liver Cancer Develop Without Symptoms?

Early liver cancer can develop silently because a small tumour may not initially interfere with the liver’s ability to function or affect surrounding structures. The liver has a considerable functional reserve, meaning that a substantial amount of healthy tissue can continue performing essential functions despite the presence of a developing tumour. As a result, early hepatocellular carcinoma (HCC) may produce few or no noticeable changes.

Symptoms are more likely to appear as a tumour grows, affects more liver tissue or begins to place pressure on nearby structures [2]. These may include persistent discomfort or pain in the upper-right abdomen, loss of appetite, unexplained weight loss, abdominal swelling or jaundice. However, the absence of these symptoms cannot be taken as reassurance that an early tumour is not present.

This is precisely why surveillance is important for people with cirrhosis who are at increased risk of HCC. Rather than waiting for symptoms to trigger an investigation, surveillance examines the liver at regular intervals with the aim of identifying suspicious changes while the cancer is still at an earlier stage.

Who Should Undergo Liver Cancer Surveillance?

Liver cancer surveillance is recommended for people whose underlying liver disease places them at a sufficiently increased risk of developing hepatocellular carcinoma (HCC) [3]. People with cirrhosis are the main group for whom regular surveillance is considered, provided their overall health and liver function are such that they could benefit from treatment if cancer were detected.

Cirrhosis can develop as a result of several chronic liver conditions, including:

• Chronic hepatitis B or hepatitis C
• Alcohol-related liver disease
• Metabolic dysfunction-associated steatotic liver disease (MASLD), particularly when it has progressed to cirrhosis
• Autoimmune liver diseases
• Inherited or metabolic liver disorders
• Other chronic liver diseases that result in cirrhosis

However, cirrhosis is not the only situation in which surveillance may be appropriate. Some people with chronic hepatitis B have an increased risk of HCC even before cirrhosis develops, and surveillance may be recommended according to factors such as age, family history, ethnicity and other clinical risk factors [4]. 

The decision to begin or continue surveillance should therefore be based on an individual assessment of the underlying liver disease and HCC risk, rather than on whether a person currently has symptoms.

How is Liver Cancer Surveillance Performed?

Liver cancer surveillance involves regularly examining the liver for early changes that may suggest hepatocellular carcinoma (HCC), even when no symptoms are present. For most people with cirrhosis who require surveillance, a liver ultrasound is performed at regular intervals, commonly together with a blood test for alpha-fetoprotein (AFP) [5].

Surveillance may include:

• Liver ultrasound — This is the main imaging test used for routine surveillance [6]. It allows the liver to be examined for newly developed nodules or other abnormalities that may require closer assessment. Ultrasound is non-invasive and does not involve ionising radiation.
• Alpha-fetoprotein (AFP) blood test — AFP is a tumour marker that can be elevated in some people with HCC [7]. However, not every liver cancer causes AFP to rise, and an elevated level can occur for other reasons. AFP is therefore interpreted alongside imaging rather than used alone to diagnose or exclude HCC.
• Comparison with previous results — Reviewing earlier scans and AFP levels can help determine whether a finding is new or whether an existing abnormality has changed over time.
• Further imaging when necessary — If ultrasound detects a suspicious nodule, or if the liver cannot be adequately assessed on ultrasound, more detailed imaging with contrast-enhanced CT or MRI may be recommended.

CT and MRI therefore have an important role in investigating abnormalities identified during surveillance, but they are not routinely required for every surveillance appointment. The imaging approach is determined by the ultrasound findings, the quality of the examination and the individual clinical situation.

Why is Surveillance Usually Performed Every Six Months?

For people who require liver cancer surveillance, six months is generally considered an appropriate interval for detecting hepatocellular carcinoma (HCC) at an earlier stage [8]. This timeframe allows the liver to be reassessed regularly enough to identify a newly developing lesion or a meaningful change, without subjecting patients to unnecessarily frequent testing.

A normal surveillance result does not mean that future screening is no longer necessary. It only indicates that no concerning abnormality was identified at that particular examination. Because the underlying risk associated with cirrhosis remains, a tumour can develop between surveillance appointments even after previous ultrasound examinations have been normal.

Liver cancer surveillance should therefore be viewed as an ongoing programme, and not a one-time test. Keeping to the recommended six-month schedule reduces the likelihood of a developing tumour remaining undetected for a prolonged period and increases the opportunity for HCC to be identified while it is still at an earlier stage.

Is AFP Alone Enough to Screen for Liver Cancer?

No. Alpha-fetoprotein (AFP) is useful as part of liver cancer surveillance, but it cannot reliably detect or exclude hepatocellular carcinoma (HCC) on its own. Some people with HCC have normal AFP levels, particularly when the tumour is small, while an elevated AFP can also occur in people who do not have liver cancer.

For this reason, AFP is interpreted together with liver imaging rather than as a stand-alone cancer test [9]. A rising or persistently elevated AFP level may warrant closer assessment, particularly in someone already at increased risk of HCC, but the result needs to be considered alongside ultrasound findings, previous AFP measurements and the person's underlying liver condition.

If AFP levels or imaging findings raise concern, further investigation may be recommended. This may include more detailed imaging with contrast-enhanced CT or MRI to determine whether a suspicious liver lesion is present and whether it has features consistent with HCC.

What Happens if Surveillance Finds a Liver Nodule?

Finding a liver nodule during surveillance does not necessarily mean that liver cancer is present. Cirrhosis itself can produce regenerative and other non-cancerous nodules, so a newly detected lesion needs to be assessed according to its size, appearance and whether it has changed compared with previous scans.

Further assessment may involve:

• Reviewing the nodule’s size and appearance — Certain imaging characteristics can help distinguish benign nodules from lesions that require further investigation.
• Comparing with previous scans — This can establish whether the nodule is new, stable or changing over time.
• Reviewing AFP levels — AFP results can provide additional information when interpreted together with imaging findings.
• Contrast-enhanced CT or MRI — More detailed imaging may be required to examine how the nodule behaves before and after contrast administration, which can help characterise the lesion.
• Specialist assessment — Suspicious or indeterminate findings may need to be reviewed by a hepatobiliary or liver specialist to determine the appropriate next step.
• Further surveillance when appropriate — Some small or indeterminate nodules may not be immediately diagnosable and may instead require repeat imaging after a defined interval.

In people at increased risk of HCC, characteristic findings on specialised contrast-enhanced imaging can sometimes establish the diagnosis without the need for a biopsy. Other nodules may remain uncertain and require additional imaging, follow-up or, in selected circumstances, tissue sampling before their nature can be determined.

How Does Early Detection Affect Liver Cancer Treatment?

The stage at which hepatocellular carcinoma (HCC) is detected can significantly influence the treatments available. When a tumour is identified at an early stage and remains confined to the liver, some patients may be suitable for treatments with curative intent. 

The choice depends not only on the size and number of tumours, but also on their location, the extent of underlying cirrhosis, liver function and the patient’s overall health. Treatment options for early-stage HCC may include:

• Liver resection — Surgical removal of the part of the liver containing the tumour may be considered when the cancer is localised and the remaining liver has sufficient functional reserve [10].
• Local ablation — Techniques that destroy tumour tissue may be suitable for selected small liver cancers, particularly when surgery is not the preferred option [11].
• Liver transplantation — For carefully selected patients, transplantation can treat both the liver cancer and the underlying cirrhosis [12].

Once HCC becomes more advanced, these potentially curative approaches may no longer be suitable, and treatment may instead involve locoregional therapies or systemic treatment. 

Regular surveillance therefore aims to detect HCC while it is still at a stage when a wider range of treatment options, including potentially curative treatment, can be considered.

Does Treating the Cause of Cirrhosis Remove the Need for Surveillance?

Not necessarily. Treating the disease responsible for cirrhosis is an important part of protecting the liver and can reduce ongoing liver damage. However, once cirrhosis has developed, successfully treating or controlling its underlying cause does not necessarily eliminate the increased risk of hepatocellular carcinoma (HCC).

For example, successful treatment of chronic hepatitis C substantially reduces the risk of HCC, but people who already have cirrhosis generally remain at increased risk even after the virus has been cleared. Similarly, stopping alcohol consumption or improving the metabolic factors contributing to liver disease can provide important benefits without necessarily removing the cancer risk associated with established cirrhosis.

Surveillance should therefore not be stopped solely because liver blood tests have improved, the underlying disease is better controlled or the person feels well. Whether ongoing HCC surveillance is required depends on the extent of liver disease and the individual’s remaining cancer risk, and should be determined by the treating doctor.

Can Normal Liver Function Tests Rule Out Liver Cancer?

No. Liver function tests are important for monitoring cirrhosis and assessing how well the liver is functioning, but normal or stable results cannot rule out hepatocellular carcinoma (HCC). An early liver tumour may be present without causing substantial changes in routine liver enzymes or other measures of liver function.

This is because blood tests and cancer surveillance serve different purposes. Routine liver blood tests assess aspects of liver injury and function, whereas HCC surveillance is specifically intended to look for evidence of a developing liver tumour. A reassuring blood test result therefore cannot replace scheduled liver imaging.

People who have been advised to undergo HCC surveillance should continue with the recommended schedule even when their liver function tests remain stable and they have no symptoms. Neither normal blood results nor the absence of symptoms reliably excludes early HCC.

When is Additional Imaging Needed During Liver Cancer Surveillance?

Ultrasound is commonly used for routine HCC surveillance, but it does not always provide a sufficiently clear view of the liver. In some people, factors such as body habitus or the irregular, nodular appearance of a cirrhotic liver can make small abnormalities more difficult to identify or assess.

Additional imaging may be needed when the liver cannot be adequately visualised on ultrasound or when ultrasound identifies a nodule or other abnormality that requires further characterisation. Depending on the findings, this may involve contrast-enhanced multiphasic CT or MRI, which can provide more detailed information about the lesion and its pattern of contrast enhancement.

This does not mean that every person undergoing HCC surveillance routinely requires CT or MRI. More detailed imaging is generally used when the quality of ultrasound is inadequate or when a finding needs further investigation, with the appropriate imaging approach determined according to the individual clinical situation.

Which Symptoms Should Be Assessed Between Surveillance Appointments?

Regular surveillance should not delay medical assessment if new symptoms develop between scheduled appointments. A previous normal ultrasound only reflects the findings at the time it was performed, and people with cirrhosis should seek medical advice if they develop a significant or unexplained change in their health.

Symptoms that warrant medical assessment may include:

• New or persistent upper-right abdominal pain
• Unexplained weight loss
• Loss of appetite
• Increasing abdominal swelling
• New or worsening jaundice
• Persistent nausea or vomiting
• Increasing weakness or a noticeable deterioration in general health
• Vomiting blood or passing black stools, which may indicate a serious complication of cirrhosis and requires prompt medical attention

These symptoms are not specific to liver cancer and can occur with cirrhosis itself or other medical conditions. However, they should be assessed when they develop rather than attributed to existing liver disease or left until the next scheduled surveillance appointment.

Why Should Surveillance Continue When You Feel Well?

Feeling well can make repeated surveillance appointments seem unnecessary, particularly when previous scans have been normal and blood tests remain stable. However, the absence of symptoms is precisely why surveillance is needed: early HCC can develop without causing noticeable changes in how a person feels.

Each surveillance examination assesses the liver at a particular point in time. A normal result six months earlier does not mean that a new lesion cannot subsequently develop, nor does stable liver function eliminate the cancer risk associated with cirrhosis.

Keeping to the recommended surveillance schedule therefore provides repeated opportunities to identify HCC before symptoms develop. If surveillance appointments have been missed or there has been a prolonged gap since the last examination, the appropriate timing of the next assessment should be discussed with the treating doctor.

Key Takeaway

Cirrhosis is an important risk factor for hepatocellular carcinoma (HCC), and the disease can develop at an early stage without causing noticeable symptoms or significant changes in routine liver blood tests. Liver cancer surveillance is therefore based on a person’s underlying risk rather than on the presence of symptoms, allowing suspicious changes to be identified before they would otherwise become clinically apparent.

For people with cirrhosis who meet surveillance criteria, regular liver ultrasound, commonly accompanied by an alpha-fetoprotein (AFP) blood test, provides an opportunity to detect HCC at an earlier stage. Surveillance generally continues at approximately six-month intervals because a normal examination reflects the liver at that point in time and does not eliminate the possibility of HCC developing subsequently. 

When ultrasound identifies an abnormality or cannot adequately assess the liver, further investigation with contrast-enhanced CT or MRI may be required. If you have cirrhosis or another chronic liver condition, schedule a consultation with a hepatobiliary specialist at Tan Siong San Surgery to assess your liver cancer risk and determine an appropriate surveillance plan.

Frequently Asked Questions (FAQs)

References 

1. Dong, Z., Wang, Y., & Jin, W. (2024). Liver cirrhosis: Molecular mechanisms and therapeutic interventions. MedComm, 5(10), e721. https://doi.org/10.1002/mco2.721 
2. Centers for Disease Control and Prevention. (2024). About liver cancer. CDC – About Liver Cancer. 
3. Elderkin, J., Al Hallak, N., Azmi, A. S., Aoun, H., Critchfield, J., Tobon, M., & Beal, E. W. (2023). Hepatocellular carcinoma: Surveillance, diagnosis, evaluation and management. Cancers, 15(21), 5118. https://doi.org/10.3390/cancers15215118 
4. Rizzo, G. E. M., Cabibbo, G., & Craxì, A. (2022). Hepatitis b virus-associated hepatocellular carcinoma. Viruses, 14(5), 986. https://doi.org/10.3390/v14050986 
5. Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A., & Singal, A. G. (2018). Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: A meta-analysis. Gastroenterology, 154(6), 1706-1718.e1. https://doi.org/10.1053/j.gastro.2018.01.064 
6. Skoczylas, K., & Pawełas, A. (2015). Ultrasound imaging of the liver and bile ducts – expectations of a clinician. Journal of Ultrasonography, 15(62), 292–306. https://doi.org/10.15557/JoU.2015.0026 
7. Hanif, H., Ali, M. J., Susheela, A. T., Khan, I. W., Luna-Cuadros, M. A., Khan, M. M., & Lau, D. T.-Y. (2022). Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World Journal of Gastroenterology, 28(2), 216–229. https://doi.org/10.3748/wjg.v28.i2.216 
8. Chang, S.-S., Chen, Y.-C., Hu, H.-Y., Yen, Y.-F., & Huang, N. (2025). Optimal surveillance intervals for hepatocellular carcinoma screening in cirrhotic patients with hepatitis C infection: A Taiwanese national cohort study. BMC Cancer, 25, 1141. https://doi.org/10.1186/s12885-025-14551-9 
9. Ahmed Mohammed, H. F., & Roberts, L. R. (2017). Should AFP (Or any biomarkers) be used for HCC surveillance? Current Hepatology Reports, 16(2), 137–145. https://doi.org/10.1007/s11901-017-0349-7 
10. Tabori, N. E., & Sivananthan, G. (2020). Treatment options for early-stage hepatocellular carcinoma. Seminars in Interventional Radiology, 37(5), 448–455. https://doi.org/10.1055/s-0040-1720950 
11. Han, S., Sung, P. S., Park, S. Y., Kim, J. W., Hong, H. P., Yoon, J.-H., Chung, D. J., Kwon, J. H., Lim, S., Kim, J. H., Shin, S. K., Kim, T. H., Lee, D. H., Choi, J. Y., & Association, R. C. of the K. L. C. (2024). Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendations of the korean liver cancer association. Gut and Liver, 18(5), 789–802. https://doi.org/10.5009/gnl240350 
12. Shimamura, T., Goto, R., Watanabe, M., Kawamura, N., & Takada, Y. (2022). Liver transplantation for hepatocellular carcinoma: How should we improve the thresholds? Cancers, 14(2), 419. https://doi.org/10.3390/cancers14020419 

At a glance

Overview	Details
Condition	Liver cysts (hepatic cysts)
What They Are	Fluid-filled spaces that develop within the liver
How They Are Often Found	Incidentally during an ultrasound, CT scan or MRI performed for another reason
Are They Usually Harmful?	Most simple liver cysts are benign and cause no symptoms or complications
Do Simple Cysts Need Treatment?	Usually not if they have typical imaging features and are not causing symptoms
Is Routine Follow-Up Needed?	Routine imaging follow-up is generally not recommended for an asymptomatic, confidently diagnosed simple hepatic cyst
When Further Assessment May Be Needed	When the cyst causes symptoms, develops a complication or has atypical or complex imaging features
Possible Treatments for Symptomatic Simple Cysts	Depending on the individual case, options may include aspiration with sclerotherapy or surgical fenestration
When to Seek Medical Attention	Significant or worsening upper abdominal pain, fever, jaundice, sudden severe pain or other new concerning symptoms

Liver cysts are frequently discovered incidentally during an ultrasound, CT scan or MRI performed for another reason. For many patients, the finding is unexpected and understandably raises questions about whether the cyst is dangerous, whether it could become cancerous and whether it needs to be removed.

In most cases, an incidental liver cyst is a simple hepatic cyst—a benign, fluid-filled lesion that causes no symptoms and does not require treatment. However, not every cystic lesion in the liver is a simple cyst, and the significance of the finding cannot be determined from the word “cyst” alone. Its appearance on imaging, the presence of symptoms and any associated complications are important in determining whether further assessment is necessary.

This is why management can differ considerably between patients. A typical simple cyst in someone without symptoms may require no further investigation or routine follow-up, whereas a symptomatic cyst or one with atypical imaging features may need additional imaging and specialist evaluation.

In this blog, we explain how simple liver cysts differ from other cystic liver lesions, when they can safely be left alone, which symptoms and imaging findings warrant closer attention and when a hepatobiliary specialist’s opinion may be appropriate.

What Exactly is a Liver Cyst?

A liver cyst, also called a hepatic cyst, is a fluid-filled cavity that develops within the liver. There are several types of cystic liver lesions, but the most common is the simple hepatic cyst, a benign cyst that is often discovered incidentally during imaging performed for another reason [1].

Simple hepatic cysts are believed to develop from small bile duct structures during development, although they do not usually communicate with the bile ducts themselves. A person may have a single cyst or several cysts, and most cause no symptoms or disruption to normal liver function.

Simple liver cysts also tend to have a recognisable appearance on imaging. On ultrasound, they typically contain clear fluid and appear as well-defined lesions with thin, smooth walls and no internal solid components or divisions. When these typical features are present in a person without symptoms, further investigation is often unnecessary.

Not all cystic lesions have this straightforward appearance, however. A cyst containing internal divisions, thickened or irregular walls, solid areas or other unusual features may represent a different type of liver lesion or a complicated cyst [2]. In these situations, further imaging with CT or MRI may be needed to establish the nature of the cyst and determine whether specialist assessment is appropriate.

Do Simple Liver Cysts Need Treatment?

In most cases, they do not. A simple liver cyst is a benign lesion, and when it has the characteristic appearance of a simple hepatic cyst on imaging and is not causing symptoms, treatment is generally unnecessary [3]. Most remain clinically insignificant and do not interfere with normal liver function or lead to complications.

Even if a simple cyst increases in size over time, this does not automatically mean that treatment is required. The decision is guided more by whether the cyst is causing symptoms, affecting nearby structures or developing complications than by a change in size alone. Similarly, once an asymptomatic cyst has been confidently identified as a simple hepatic cyst, routine imaging follow-up is generally not required.

Observation is therefore appropriate for most people with uncomplicated simple liver cysts. The approach may change if symptoms develop, complications such as bleeding or infection are suspected, or subsequent imaging raises uncertainty about the nature of the lesion. In these circumstances, further investigation or specialist assessment may be appropriate.

Distinguishing Simple from Complex Liver Cysts

The characteristics of a liver cyst on imaging are central to determining its likely nature and whether further assessment is necessary. A typical simple hepatic cyst has a well-defined, thin and smooth wall, contains uniform fluid and has no internal septations or solid components. These features generally support a benign diagnosis when considered alongside the patient’s clinical presentation.

By contrast, findings such as internal septations, wall thickening or irregularity, mural nodules, calcification or internal debris may indicate a complicated cyst or another type of cystic liver lesion [4]. Such findings do not necessarily indicate malignancy, but they may warrant additional imaging or specialist assessment to establish the diagnosis and determine appropriate management.

Feature	Typical Simple Liver Cyst	Features That May Require Further Assessment
Contents	Clear, uniform fluid	Internal debris, blood or more complex contents
Wall	Thin and smooth	Thickened or irregular wall
Internal Divisions	Usually absent	Septations or multiple compartments
Solid Components	Absent	Mural nodules or solid components
Contrast Enhancement	No enhancement of the cyst contents	Enhancing walls, septa or solid tissue may require investigation
Symptoms	Usually none	Pain, pressure symptoms, fever or other associated symptoms may require assessment
Usual Approach	Observation if asymptomatic	Further characterisation and specialist assessment may be required

When atypical features are present, further evaluation may be needed to clarify the nature of the lesion and distinguish a complicated simple cyst from other cystic liver conditions. Depending on the initial findings, CT or MRI may be used to characterise the cyst in greater detail and guide subsequent management.

Does the Size of a Liver Cyst Determine Whether It Is Dangerous?

It is natural to focus on size when a scan describes a liver cyst as “large”, but size alone does not determine whether a cyst is concerning or needs treatment. A large simple cyst may remain harmless and cause no symptoms, while a much smaller cyst may need closer assessment if it has unusual features on imaging.

Instead of looking at the measurement alone, doctors consider the cyst as a whole. Important questions include:

• Does it have the typical appearance of a simple liver cyst?
• Is it causing pain, abdominal fullness or other symptoms?
• Is it pressing on the stomach, bile ducts or other nearby structures?
• Are there signs of bleeding, infection or another complication?
• Does it contain septations, nodules or other atypical features?
• Is it a single cyst, or are there multiple cysts that may suggest another cystic liver condition?

Size becomes more relevant when a cyst begins to have a physical effect. A sufficiently large cyst may stretch the liver capsule or compress nearby structures, potentially causing pain, abdominal fullness, early satiety or, in some cases, problems with bile drainage. In these situations, treatment may be considered because of what the cyst is causing, rather than simply because it has reached a particular size.

When Can a Liver Cyst Start Causing Symptoms?

Most simple liver cysts cause no symptoms at all. When symptoms do occur, they are more likely to arise when a cyst becomes sufficiently large to exert pressure on surrounding structures or when a complication develops [5].

Possible symptoms include:

• Dull or persistent discomfort in the right upper abdomen
• A sensation of abdominal fullness or pressure
• Abdominal distension
• Feeling full sooner than expected when eating
• Nausea in some patients

These symptoms are not specific to liver cysts. Gallbladder disease, stomach conditions, bowel disorders and many other abdominal problems can produce similar complaints. Finding a cyst on a scan therefore does not prove that the cyst is responsible for a patient’s symptoms.

This is particularly important when treatment is being considered. A specialist assessment can help determine whether the location and size of the cyst plausibly explain the symptoms or whether another cause needs to be investigated.

What Complications Can Develop from a Liver Cyst?

Most simple liver cysts remain uncomplicated and never cause significant problems. Complications are uncommon, but they can occur, particularly in larger or symptomatic cysts. When they do, the symptoms and appearance of the cyst may change and further medical assessment may be necessary.

• Bleeding into the cyst — Occasionally, bleeding can occur within a liver cyst, known as intracystic haemorrhage [6]. This may cause sudden or worsening upper abdominal pain and can change the internal appearance of the cyst on imaging. Because bleeding can make a previously simple cyst appear more complex, additional imaging may be needed to confirm the cause of the change and exclude other cystic lesions.
• Cyst infection — A liver cyst can become infected, although this is uncommon. Infection may cause fever, upper-right abdominal pain or tenderness and other signs of inflammation or infection [7]. Changes may also be visible within or around the cyst on imaging. An infected cyst requires medical assessment and appropriate treatment rather than continued observation alone.
• Compression of nearby structures — A large cyst may place pressure on surrounding organs or structures. Depending on its size and location, this can contribute to persistent abdominal discomfort, fullness or early satiety. Less commonly, compression of the bile ducts can interfere with bile drainage and contribute to jaundice.
• Cyst rupture — Rarely, a liver cyst can rupture, allowing its contents to leak into the abdominal cavity [8]. This may cause sudden abdominal pain and requires prompt medical assessment, particularly when the pain is severe or accompanied by other new symptoms.

The development of a complication changes how a liver cyst is managed. A cyst that was previously suitable for observation may require further imaging, specialist assessment or treatment if bleeding, infection, rupture or significant compression develops.

When Does a Liver Cyst Need a Specialist’s Opinion?

Not every incidental simple cyst needs specialist referral simply because it has been identified. A specialist opinion becomes more relevant when there is uncertainty about what the lesion is, whether it is responsible for symptoms or whether intervention may be necessary.

Further assessment may be appropriate when:

• The cyst has septations, wall thickening, irregularity, nodules or other complex features
• The diagnosis of a simple cyst is uncertain
• Persistent or recurrent symptoms may be attributable to the cyst
• A large cyst is compressing nearby structures
• There is concern about bleeding into the cyst
• Infection is suspected
• Jaundice or evidence of bile duct obstruction develops
• There are numerous liver cysts suggesting polycystic liver disease
• Imaging raises the possibility of a parasitic or cystic neoplastic lesion
• Treatment of a symptomatic cyst is being considered

The purpose of specialist assessment is not necessarily to recommend surgery. In many cases, it is to establish what type of cyst is present and whether anything needs to be done at all.

A hepatobiliary surgeon can review the imaging alongside the patient’s symptoms, medical history and other investigations to determine whether observation, additional imaging or treatment is appropriate.

Not Every Cystic Liver Lesion is a Simple Cyst

Although simple hepatic cysts are benign, not every fluid-containing or cyst-like lesion identified in the liver belongs to this category. Several other conditions can have a cystic appearance on imaging, which is why lesions with atypical features may require further investigation before their nature can be established.

• Polycystic liver disease — Unlike an isolated simple cyst, polycystic liver disease is characterised by the presence of numerous cysts throughout the liver [9]. It can occur as a separate inherited condition or in association with autosomal dominant polycystic kidney disease. Liver function is often preserved, although extensive cysts can enlarge the liver and cause abdominal fullness, discomfort or other pressure-related symptoms.
• Hydatid cysts — These cysts develop as a result of infection with Echinococcus parasites and are managed differently from simple hepatic cysts [10]. A person’s exposure or travel history, together with characteristic findings on imaging, can help doctors determine whether hydatid disease needs to be considered.
• Mucinous cystic neoplasms of the liver — These are uncommon cystic tumours that require distinction from simple liver cysts because their management is different [11]. Imaging may reveal features such as internal septations, wall thickening or mural nodules. When these or other suspicious features are present, further characterisation is important before treatment is planned.
• Liver abscesses — A liver abscess is a collection of infected material within the liver rather than a true simple cyst. It may be associated with fever, abdominal pain, tenderness and other signs of infection. Imaging, together with the patient’s symptoms and clinical findings, helps distinguish an abscess from other cystic liver lesions.

These conditions do not mean that an incidental liver cyst should automatically be considered concerning. Rather, they highlight the importance of establishing whether a lesion has the typical features of a simple hepatic cyst.

When the appearance is atypical or the diagnosis remains uncertain, further imaging or specialist assessment may be needed to determine the nature of the lesion and the appropriate next step.

Do You Need Regular Scans for a Simple Liver Cyst?

For most people with an asymptomatic simple liver cyst, routine follow-up scans are not necessary. Once imaging has clearly established that the lesion has the typical features of a simple hepatic cyst, and there are no associated symptoms or complications, regular ultrasound, CT or MRI solely to monitor the cyst is generally not recommended.

This is because simple cysts are benign, and changes in size alone do not usually determine whether treatment is required. Repeatedly measuring a cyst that continues to have a typical appearance and causes no symptoms is therefore unlikely to change its management. Instead, further imaging is usually guided by a change in the clinical situation.

Repeat imaging may be appropriate if:

• New or persistent symptoms develop
• The initial scan does not clearly establish that the lesion is a simple cyst
• Atypical or complex features require further characterisation
• Bleeding, infection or another complication is suspected
• Another liver condition requires ongoing imaging surveillance
• A specialist recommends reassessment based on the individual clinical findings

The need for follow-up therefore depends on why another scan is being performed. Routine surveillance is generally unnecessary for a confirmed, asymptomatic simple hepatic cyst, whereas new symptoms, uncertain imaging findings or suspected complications may provide a clear reason for further investigation.

How are Liver Cysts Diagnosed and Assessed?

Liver cysts are usually identified through an abdominal ultrasound, although they may also be detected on CT or MRI performed for another reason. Once a cyst is found, the main purpose of assessment is to determine whether it has the typical features of a simple hepatic cyst or requires further investigation.

Doctors may consider:

• The appearance of the cyst — A simple cyst typically has a thin, smooth wall, uniform fluid contents and no internal septations or solid components.
• Whether complex features are present — Septations, wall thickening or irregularity, mural nodules, debris or other atypical findings may require closer evaluation.
• Whether symptoms are present — Persistent abdominal pain, fullness or other  symptoms may influence whether further assessment is needed.
• Whether complications are suspected — Findings suggesting bleeding, infection, rupture or compression of nearby structures may require additional investigation.
• Whether further imaging is necessary — CT or MRI may be recommended when ultrasound does not clearly establish the nature of the cyst or when more detailed characterisation is required.
• The wider clinical context — Medical history, previous imaging and relevant exposure or travel history may help distinguish a simple cyst from other cystic liver conditions.

For a clearly defined, asymptomatic simple hepatic cyst, ultrasound may be all that is required. Further investigation is generally reserved for cysts that are symptomatic, complicated or cannot be confidently characterised as simple.

What Treatment Options are Available for a Symptomatic Liver Cyst?

Most simple liver cysts do not require treatment. When a simple hepatic cyst is causing clinically significant symptoms or complications, however, treatment may be considered to reduce the cyst and relieve the problems associated with it. 

The choice of treatment depends on the cyst’s size, location and anatomy, as well as the patient’s symptoms and overall clinical circumstances.

• Aspiration with sclerotherapy — This minimally invasive approach involves draining fluid from the cyst using a needle or catheter placed under imaging guidance [12]. A sclerosing agent may then be introduced to act on the cyst lining and reduce the likelihood of fluid accumulating again. Aspiration alone is generally less effective as a long-term treatment because the cyst may refill when its fluid-producing lining remains intact.
• Laparoscopic fenestration or deroofing — This procedure involves removing part of the cyst wall so that the cyst no longer remains a closed, fluid-filled cavity [13]. Where the location and anatomy of the cyst are suitable, fenestration may be performed using a laparoscopic, or keyhole, approach.
• Liver resection — Removal of part of the liver is not routinely required for an uncomplicated simple hepatic cyst [14]. It may be considered in selected cases where the location or nature of the lesion makes other approaches unsuitable, or where the underlying diagnosis requires complete surgical removal.

The appropriate treatment is therefore individualised. A hepatobiliary specialist will consider the type of cyst, the symptoms or complications it is causing, its location and anatomy, and the relative benefits and risks of the available treatment options before recommending an approach.

Key Takeaway

Most liver cysts are simple hepatic cysts that are benign, cause no symptoms and require no treatment. When a cyst has the typical features of a simple cyst on imaging and there are no associated symptoms or complications, routine follow-up scans are generally unnecessary. Size alone is also not an indication for treatment; even a relatively large simple cyst may be managed conservatively if it is not causing problems.

Further assessment becomes important when the clinical or imaging picture is less straightforward. Persistent symptoms, compression of nearby structures, bleeding, infection or rupture may change how a previously simple cyst is managed. 

Similarly, features such as internal septations, wall thickening or irregularity, nodules or solid components may require additional imaging to distinguish a complicated simple cyst from other cystic liver conditions. When treatment is necessary for a symptomatic simple cyst, options such as aspiration with sclerotherapy or laparoscopic fenestration may be considered depending on the individual case.

If you have been diagnosed with a liver cyst and are unsure what the finding means or whether further assessment is necessary, consider scheduling a consultation with a hepatobiliary specialist at Tan Siong San Surgery for an individual assessment of your imaging findings and advice on whether observation, further investigation or treatment may be appropriate.

Frequently Asked Questions (FAQs)

References 

1. Rawla, P., Sunkara, T., Muralidharan, P., & Raj, J. P. (2019). An updated review of cystic hepatic lesions. Clinical and Experimental Hepatology, 5(1), 22–29. https://doi.org/10.5114/ceh.2019.83153 
2. Baltagiannis, E. G., Tsili, A., Goussia, A., Glantzouni, A., Frigkas, K., Charchanti, A., Glantzounis, G. K., & Gomatos, I. P. (2024). Complex cystic liver lesions: Classification, diagnosis, and management. Annals of Gastroenterology, 37(3), 255–265. https://doi.org/10.20524/aog.2024.0876 
3. Rho, S. Y., Lee, J.-M., Park, M.-S., Kang, W.-H., Byun, Y., Lee, S. J., Shin, A., Yoon, J. H., Kim, B., & Yi, N.-J. (2025). Diagnosis, treatment and prognosis of simple hepatic cyst: Clinical practice guideline. Annals of Hepato-Biliary-Pancreatic Surgery, 29(3), 218–225. https://doi.org/10.14701/ahbps.25-070 
4. Loaiza, S. C., Torre, C. de la, Lozada, L. R., & Moslero, M. C. C. (2014, March 6). Differential diagnosis of complex liver cysts. European Congress of Radiology - ECR 2014. ECR 2014  EPOS. https://epos.myesr.org/poster/esr/ecr2014/C-0801 
5. Agrawal, A., Elnashar, M., Garg, K., Mustafa, A., Rosenzveig, A., Arockiam, A. D., Haroun, E., Khurana, R., Klein, A. L., & Wang, T. K. M. (2026). Contemporary review of clinical features, multi-modality imaging, and management of pericardial cysts. Journal of Clinical Medicine, 15(4), 1585. https://doi.org/10.3390/jcm15041585 
6. Purdy, A. C., Grigorian, A., Fernando, D., Nahmias, J., & Demirjian, A. N. (2019). Intracystic hemorrhage complicating polycystic liver disease in a 90-year-old woman. ACG Case Reports Journal, 6(4), e00049. https://doi.org/10.14309/crj.0000000000000049 
7. Kazuhiko Morii, Takeharu Yamamoto, Shinichiro Nakamura, Hiroaki Okushin. Infectious Hepatic Cyst: An Underestimated Complication. https://pubmed.ncbi.nlm.nih.gov/29526959/ 
8. Miliadis, L., Giannakopoulos, T., Boutsikos, G., Terzis, I., & Kyriazanos, I. D. (2010). Spontaneous rupture of a large non-parasitic liver cyst: A case report. Journal of Medical Case Reports, 4, 2. https://doi.org/10.1186/1752-1947-4-2 
9. Norcia, L. F., Watanabe, E. M., Hamamoto Filho, P. T., Hasimoto, C. N., Pelafsky, L., de Oliveira, W. K., & Sassaki, L. Y. (2022). Polycystic liver disease: Pathophysiology, diagnosis and treatment. Hepatic Medicine : Evidence and Research, 14, 135–161. https://doi.org/10.2147/HMER.S377530 
10. Xu, Y., Hu, X., Li, J., & Dong, R. (2020). Hepatic hydatid cyst misdiagnosed as simple cyst: A case report. The American Journal of Case Reports, 21, e923281-1-e923281-6. https://doi.org/10.12659/AJCR.923281 
11. Hutchens, J. A., Lopez, K. J., & Ceppa, E. P. (2023). Mucinous cystic neoplasms of the liver: Epidemiology, diagnosis, and management. Hepatic Medicine : Evidence and Research, 15, 33–41. https://doi.org/10.2147/HMER.S284842 
12. Dong, Z., Zhao, M., Chen, J., Zhao, Y., Sun, X., Huang, B., & He, Y. (2025). Giant cysts, no incisions: Ultrasound-guided sclerotherapy in the elderly. Medicine, 104(52), e46897. https://doi.org/10.1097/MD.0000000000046897 
13. Bernts, L. H. P., Echternach, S. G., Kievit, W., Rosman, C., & Drenth, J. P. H. (2019). Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: A systematic review and meta-analysis. Surgical Endoscopy, 33(3), 691–704. https://doi.org/10.1007/s00464-018-6490-8 
14. Macedo, F. I. (2013). Current management of noninfectious hepatic cystic lesions: A review of the literature. World Journal of Hepatology, 5(9), 462–469. https://doi.org/10.4254/wjh.v5.i9.462 

At a glance 

Overview	Details
Condition	Silent or asymptomatic gallstones
What it Means	Gallstones are present in the gallbladder but have not caused typical gallstone symptoms
How They are Found	Often discovered incidentally during an abdominal ultrasound or other imaging performed for another reason
Do They Always Need Treatment?	No. Most people with asymptomatic gallstones in an otherwise normal gallbladder and biliary tree do not require treatment unless symptoms develop
Usual Approach	Observation is generally appropriate when gallstones are confined to the gallbladder and are not causing symptoms or complications
When Surgery Becomes More Relevant	If typical biliary symptoms develop, complications occur or particular clinical circumstances make preventive treatment appropriate
Possible Complications	Gallstones can occasionally lead to biliary colic, acute cholecystitis, bile duct obstruction, cholangitis or gallstone pancreatitis
Surgical Treatment	When gallbladder removal is indicated, laparoscopic cholecystectomy is generally the standard surgical approach
When to Seek Medical Attention	New or persistent upper abdominal pain, fever, jaundice, persistent vomiting or significant abdominal tenderness should be assessed

Gallstones are often discovered incidentally during an abdominal ultrasound performed for a health screening or while investigating an unrelated concern. For someone who has never experienced typical gallstone pain or a gallstone-related complication, seeing “gallstones” on an imaging report can raise an immediate question: if the stones are not causing any problems now, should they be removed before they do?

In most cases, the answer is no. The presence of gallstones alone does not mean that surgery is necessary. When stones remain within the gallbladder, cause no symptoms and are not associated with abnormalities of the gallbladder or biliary system, they can usually be left untreated. Current NICE guidance recommends reassurance and no treatment for people with asymptomatic gallbladder stones when the gallbladder and biliary tree are otherwise normal, unless symptoms subsequently develop [1].

This approach reflects an important principle in gallstone management: treatment should be guided by the clinical significance of the stones, not simply by their presence on a scan. For many people, gallstones remain silent throughout life and never create a reason for intervention.

In this blog, we explain what silent gallstones are, why they often do not require treatment, what can happen if they are left alone and the circumstances in which gallbladder removal may still be considered.

What are Silent Gallstones?

Gallstones are solid deposits that form from components of bile within the gallbladder. They can vary considerably in size and number, from fine deposits or small stones to larger individual stones.

The term “silent gallstones” refers to gallstones that are present without causing the typical symptoms or complications associated with gallstone disease [2]. A person may have one or several stones in the gallbladder for years without knowing they are there. In many cases, they are discovered incidentally when an ultrasound, CT scan or other abdominal investigation is performed for an unrelated reason.

This absence of symptoms is more than a description of how the patient feels; it is an important part of deciding whether treatment is necessary. A gallstone that has remained confined to the gallbladder without causing biliary pain, inflammation or obstruction is approached differently from a stone that has already produced symptomatic disease [3].

It is also important to distinguish asymptomatic gallbladder stones from stones in the common bile duct. Once a stone has migrated from the gallbladder into the common bile duct, it can obstruct the normal flow of bile and create potentially serious complications. NICE therefore recommends bile duct clearance for common bile duct stones even when they have not yet caused symptoms, with laparoscopic cholecystectomy also offered to appropriate patients [4].

In other words, being told that you have an “asymptomatic gallstone” is not enough information on its own. Where the stone is located and whether there are associated abnormalities are also important when deciding what should happen next.

Why Silent Gallstones Usually Do Not Need Surgery

The discovery of gallstones can make preventive removal seem logical: if the stones have the potential to cause problems in the future, why not remove the gallbladder before that happens? For most people with genuinely asymptomatic gallstones, however, the potential benefit of preventive surgery is not sufficient to justify routinely operating on an otherwise symptom-free patient.

One reason is that many silent gallstones never become symptomatic. European Association for the Study of the Liver (EASL) guidance reports that approximately 0.7–2.5% of people with asymptomatic gallstones develop symptoms each year, while serious gallstone-related complications occur at a considerably lower annual rate [5]. This means that the presence of gallstones does not make future illness inevitable.

Surgery also needs to offer a meaningful benefit to justify exposing a patient to an operation. Cholecystectomy, or surgical removal of the gallbladder, is an established and effective treatment for symptomatic gallstone disease [6]. However, like any operation, it involves anaesthesia and carries potential surgical complications. Removing the gallbladder from every person in whom an incidental stone is detected would therefore mean operating on many people who might never have developed a problem from their gallstones.

For this reason, the decision can be understood as a balance between two risks:

• Leaving the gallstones in place carries a relatively low possibility that symptoms or complications will develop in the future.

• Removing the gallbladder preventively exposes a currently well person to the immediate risks and recovery associated with surgery.

When gallstones are asymptomatic and there are no other clinical reasons for intervention, the balance generally favours observation. This is why major clinical guidance does not routinely recommend prophylactic cholecystectomy simply because gallstones have been identified.

Importantly, observation does not mean that the finding has been dismissed. It means that there is currently no sufficient clinical benefit from intervention to outweigh the disadvantages of surgery. The patient should understand the finding, recognise symptoms that may indicate a change and seek reassessment if those symptoms develop.

What Happens if Silent Gallstones are Left Alone?

For many people, nothing happens. The stones remain within the gallbladder without producing symptoms, sometimes for many years. This is precisely why routine surgery is generally unnecessary for uncomplicated asymptomatic gallstones.

A proportion of people will eventually develop symptoms, but it is not possible to predict with certainty which individual patient will do so. When problems occur, they usually begin when a stone interferes with the normal drainage of bile or moves into the biliary ducts.

The first indication that previously silent stones have become clinically significant may be biliary colic, typically a sustained episode of pain in the upper abdomen caused by temporary obstruction of the gallbladder outlet [7]. Other possible complications include:

• Acute cholecystitis — inflammation of the gallbladder, usually following persistent obstruction of the cystic duct [8].
• Common bile duct stones (choledocholithiasis) — stones that migrate into the common bile duct and may obstruct bile flow [9].
• Obstructive jaundice — yellowing of the skin or eyes when bile drainage becomes obstructed [10].
• Cholangitis — infection within an obstructed biliary system, which can become a medical emergency [11].
• Gallstone pancreatitis — inflammation of the pancreas triggered when a migrating stone obstructs the region where the bile and pancreatic ducts drain [12].

Although these complications are important, their possibility should be kept in perspective when considering an asymptomatic patient. EASL guidance reports that complications in people with asymptomatic gallstones occur at relatively low annual rates, supporting conservative management for most patients who have never experienced symptoms [13].

What matters is a change in the clinical picture. Once a person begins experiencing characteristic biliary pain or develops a gallstone-related complication, the stones can no longer be considered truly silent. At that point, the balance between observation and treatment needs to be reassessed.

Silent Gallstones vs Symptomatic Gallstone Disease

The distinction between silent and symptomatic gallstones is clinically important because the same finding on an ultrasound can lead to very different management depending on what the stones are doing.

Feature	Silent Gallstones	Symptomatic Gallstones
Symptoms	No typical gallstone symptoms	Biliary pain or other gallstone-related symptoms have occurred
How They May Be Found	Often discovered incidentally during imaging	Frequently identified during investigation of symptoms
Immediate Treatment	Usually unnecessary in uncomplicated cases	Treatment is more likely to be indicated
Usual Management	Observation and awareness of symptoms	Clinical or surgical assessment
Cholecystectomy	Not routinely recommended solely because stones are present	Commonly recommended for suitable patients with symptomatic gallbladder stones
What Changes Management	Development of symptoms, complications or other relevant clinical findings	Frequency and severity of symptoms, complications and the patient’s overall health

The important dividing line is therefore not simply whether gallstones are present, but whether they have begun to cause clinically meaningful disease. A person whose gallstones were appropriately observed when they were first discovered may later become a candidate for surgery if recurrent biliary pain or a gallstone-related complication develops. Management can therefore change over time as the clinical significance of the stones changes.

When Surgery May Be Considered Despite Having No Symptoms

Observation is appropriate for most people with uncomplicated silent gallstones, but there are selected situations in which surgery may still be discussed even when typical gallstone symptoms are absent. These decisions are usually based on the wider clinical picture, not on the presence of gallstones alone.

A specialist may take a different approach when there are additional findings involving the gallbladder or biliary system, or when an individual’s medical circumstances make a future gallstone complication more difficult to manage. Examples may include:

• Concerning abnormalities of the gallbladder identified on imaging
• Certain gallbladder polyps or other lesions occurring alongside gallstones
• Stones within the common bile duct, which are managed differently from stones confined to the gallbladder
• Selected medical conditions in which the consequences of a future gallstone complication could be particularly significant
• Certain major abdominal procedures, where the presence of gallstones may need to be considered as part of broader surgical planning

These situations require individual assessment because the evidence and recommendations are not identical for every patient or clinical scenario. A finding that increases concern in one person may not carry the same significance in another.

Does the Size or Number of Silent Gallstones Matter?

It is common to assume that a very large gallstone must be removed, while a small stone is relatively harmless. In practice, stone size alone does not determine whether surgery is necessary, and the same is true of the number of stones present.

A person may have several gallstones without ever experiencing symptoms, while another person with a single stone may develop biliary pain or a complication. What matters more is how the stones are behaving and where they are located.

When reviewing an ultrasound, a doctor may consider:

• whether the stones are confined to the gallbladder
• whether there are signs of gallbladder inflammation
• whether the bile ducts are dilated or contain stones
• whether other gallbladder abnormalities are present
• whether the patient has experienced symptoms that could be related to gallstones
• the patient's overall medical circumstances

Certain unusual stone or gallbladder characteristics may influence specialist recommendations in selected cases, but there is no simple rule that a particular stone size or number automatically means surgery is required.

For that reason, the measurement recorded on an ultrasound report should not be interpreted in isolation. The significance of a stone depends on the complete clinical and imaging assessment.

Do You Need Regular Ultrasounds for Silent Gallstones?

If gallstones have been found incidentally, patients sometimes expect that they will need regular scans to check whether the stones are growing. For uncomplicated asymptomatic gallstones, however, routine serial ultrasound is generally not required simply to monitor stone size or number.

This is because management is usually influenced more by whether symptoms develop or the clinical situation changes than by small differences in stone measurements between scans. A gallstone becoming slightly larger on imaging does not automatically mean that treatment is needed.

Repeat imaging may still be appropriate when there is another reason to reassess the gallbladder, such as:

• an additional gallbladder abnormality requiring surveillance
• uncertainty about the original imaging finding
• new abdominal or biliary symptoms
• changes in liver tests or other clinical findings
• a specialist recommendation based on the individual’s circumstances

Patients with straightforward silent gallstones are therefore usually advised to remain aware of relevant symptoms and seek medical review if their condition changes, instead of undergoing repeated scans solely because stones are present.

Symptoms That Mean Your Gallstones are No Longer “Silent”

Silent gallstones become clinically important when they begin causing symptoms or interfere with the normal drainage of bile. New symptoms should therefore prompt reassessment, particularly when they are persistent, recurrent or severe.

Symptoms that may require medical attention include:

• Persistent or recurrent pain in the upper-right or upper-central abdomen
• Pain extending towards the back or right shoulder
• Fever or chills accompanying abdominal pain
• Persistent nausea or vomiting
• Jaundice, including yellowing of the skin or eyes
• Marked abdominal tenderness
• Feeling significantly unwell together with abdominal symptoms

Typical gallstone pain often occurs when a stone temporarily obstructs the outlet of the gallbladder. More persistent pain, particularly when accompanied by fever or tenderness, may indicate inflammation. Jaundice can suggest obstruction within the bile ducts and requires prompt assessment.

It is also important not to assume that every episode of abdominal discomfort in someone with gallstones must be caused by them. Indigestion, reflux, peptic disease, liver conditions and other abdominal disorders can produce overlapping symptoms. A medical assessment helps determine whether the gallstones are actually responsible and whether management needs to change.

From Observation to Surgery: When the Management Changes

Silent gallstones usually remain under observation because they are not causing symptoms or complications. Surgery becomes more relevant when that changes, for example, when a person develops recurrent biliary pain, gallbladder inflammation, bile duct stones or gallstone pancreatitis.

For suitable patients with symptomatic gallstones, laparoscopic cholecystectomy is generally the standard definitive treatment. The gallbladder is removed together with the stones because leaving the gallbladder in place means new stones can form and symptoms may recur.

Surgery is not recommended on symptoms alone without considering the wider picture. Doctors also take into account:

• frequency and severity of symptoms
• previous gallstone-related complications
• ultrasound or other imaging findings
• general health and anaesthetic risk
• overall suitability for surgery

A person may therefore be observed safely while the stones remain silent and later be considered for surgery if they begin causing clinically significant problems.

Living with Silent Gallstones

Most people with silent gallstones can continue their usual daily activities without special restrictions. Work, exercise and travel can generally continue as normal unless another health condition limits them.

A strict fat-free diet is also not routinely necessary simply because gallstones have been found. A balanced diet, stable healthy weight and avoidance of rapid weight loss are generally more appropriate.

The main practical advice is to remain alert to changes. If meals repeatedly trigger upper abdominal pain, or if symptoms such as persistent pain, fever, vomiting or jaundice develop, medical reassessment is important because the gallstones may no longer be truly silent.

Key Takeaway 

Finding gallstones unexpectedly can make preventive surgery seem like the safest option, particularly when patients are concerned about what might happen in the future. However, the presence of gallstones alone does not generally justify removing an otherwise normal, symptom-free gallbladder. 

Many silent gallstones never cause a problem, and for most people with uncomplicated asymptomatic stones, observation is an appropriate management strategy. The decision changes when the clinical situation changes. Recurrent biliary pain, gallbladder inflammation, stones entering the bile ducts, jaundice, pancreatitis or other complications may create a clear reason to reconsider treatment. 

Additional gallbladder abnormalities or individual medical circumstances can also influence the decision in selected patients. This is why management should be based on the whole clinical picture, not simply the presence, size or number of stones seen on an ultrasound report.

If gallstones have been discovered unexpectedly and you are unsure whether observation or treatment is appropriate, consider scheduling a consultation with a specialist at Tan Siong San Surgery for an individual assessment and discussion of your scan findings.

Frequently Asked Questions (FAQs) 

References 

1. NICE. (2014, October 29). Recommendations | Gallstone disease: Diagnosis and management | Guidance | NICE. https://www.nice.org.uk/guidance/cg188/chapter/Recommendations 
2. Goswami, A. G., & Basu, S. (2024). Cracking the silent gallstone code: Wait or operate? World Journal of Clinical Cases, 12(16), 2692–2697. https://doi.org/10.12998/wjcc.v12.i16.2692 
3. Gupta, V., Abhinav, A., Vuthaluru, S., Kalra, S., Bhalla, A., Rao, A. K., Goyal, M. K., & Vuthaluru, A. R. (n.d.). The multifaceted impact of gallstones: Understanding complications and management strategies. Cureus, 16(6), e62500. https://doi.org/10.7759/cureus.62500 
4. NICE. (2014, October 29). Recommendations | Gallstone disease: Diagnosis and management | Guidance | NICE. https://www.nice.org.uk/guidance/cg188/chapter/Recommendations 
5. European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu. (2016). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. Journal of Hepatology, 65(1), 146–181. https://doi.org/10.1016/j.jhep.2016.03.005 
6. Shabanzadeh, D. M. (2023). The symptomatic outcomes of cholecystectomy for gallstones. Journal of Clinical Medicine, 12(5), 1897. https://doi.org/10.3390/jcm12051897 
7. Johnson, C. D. (2001). Upper abdominal pain: Gall bladder. BMJ : British Medical Journal, 323(7322), 1170–1173. https://doi.org/10.1136/bmj.323.7322.1170 
8. Acute cholecystitis. (2017, October 17). Nhs.Uk. https://www.nhs.uk/conditions/acute-cholecystitis/ 
9. McNicoll, C. F., Pastorino, A., Farooq, U., Froehlich, M. J., & St Hill, C. R. (2026). Choledocholithiasis. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK441961/ 
10. Obstructive jaundice | center for advanced digestive care—Newyork-presbyterian/weill cornell medical center. (n.d.). NewYork-Presbyterian. Retrieved August 28, 2026, from https://www.nyp.org/cadc/liver-diseases-and-transplantation/obstructive-jaundice 
11. Ahmed, M. (2018). Acute cholangitis—An update. World Journal of Gastrointestinal Pathophysiology, 9(1), 1–7. https://doi.org/10.4291/wjgp.v9.i1.1 
12. Isogai, M. (2024). Pathophysiology of severe gallstone pancreatitis: A new paradigm. World Journal of Gastroenterology, 30(7), 614–623. https://doi.org/10.3748/wjg.v30.i7.614 
13. Prevention, diagnosis and treatment of gallstones. EASL-The Home of Hepatology. Retrieved August 28, 2026, from https://easl.eu/publication/prevention-diagnosis-and-treatment-of-gallstones/   

At a glance 

Overview	Details
Conditions Covered	Gallstones and gallbladder polyps
Main Difference	Gallstones are solid deposits that form within bile, while gallbladder polyps are growths arising from the gallbladder wall
How They Are Found	Both are commonly detected on abdominal ultrasound, sometimes incidentally
Symptoms	Gallstones are more likely to cause biliary pain and complications; gallbladder polyps are usually asymptomatic
Main Health Concern	Gallstones may cause inflammation, bile duct blockage or pancreatitis, while gallbladder polyps are assessed mainly for features associated with malignancy risk
Role of Size	Stone size alone usually does not determine treatment; polyp size is an important factor in deciding whether surveillance or surgery is needed
Assessment	Ultrasound is usually the first-line investigation, with attention to mobility, acoustic shadowing, size, morphology and gallbladder wall features
Treatment Approach	Asymptomatic gallstones often require no treatment, while symptomatic or complicated stones may require surgery; polyps may be observed, monitored or removed depending on size and risk features
Surgery	Cholecystectomy removes the entire gallbladder and may be recommended for symptomatic gallstones or gallbladder polyps that meet criteria for surgical management
When to Seek Medical Advice	Severe or persistent upper abdominal pain, fever, jaundice, persistent vomiting or worsening symptoms should be medically assessed

An abdominal ultrasound may reveal an unexpected abnormality in the gallbladder, even when the scan was performed for an entirely different reason. When the report identifies a gallstone or gallbladder polyp, it is important to understand that these findings arise differently and are assessed for different reasons. Their presence alone does not necessarily indicate a serious condition or mean that treatment is required.

Gallstones are solid deposits that develop from components of bile within the gallbladder, whereas gallbladder polyps are projections arising from its inner lining. Many gallstones remain completely asymptomatic, and most gallbladder polyps detected on ultrasound are benign. However, gallstones can become clinically important when they cause pain, obstruction or inflammation, while the significance of a polyp depends largely on characteristics such as its size, appearance, growth and associated risk factors.

In this blog, we explain the differences between gallstones and gallbladder polyps, the symptoms and complications they may cause, how they are assessed on imaging and the factors that determine whether monitoring or treatment may be needed.

Two Different Findings Inside the Gallbladder

The gallbladder is a small organ located beneath the liver. It stores and concentrates bile, a digestive fluid produced by the liver that helps with the digestion and absorption of fats. Gallstones and gallbladder polyps can both be identified during an ultrasound examination of this organ, but they originate in different places.

A gallstone develops within bile when certain substances crystallise and gradually form solid material [1]. The resulting stone lies within the cavity of the gallbladder and is usually able to move when the patient’s position changes.

A gallbladder polyp originates from the gallbladder wall [2]. It projects from the lining into the cavity of the gallbladder and generally remains attached to the wall.

Both can be incidental findings, discovered during imaging performed for another medical reason. This does not mean that either should be ignored, but it also does not mean that every gallstone or polyp requires treatment. The significance of the finding depends on its characteristics, the patient's symptoms and the risk of future complications.

Understanding Gallstones and Why They Form

Bile contains cholesterol, bile salts, bilirubin and other substances. Gallstones develop when conditions within the bile favour crystallisation and the gradual formation of solid deposits. Cholesterol stones are the most common type in many populations, while pigment stones, which contain bilirubin-related material, form through different mechanisms.

Gallstones vary considerably in size and number. Some people have a single stone, while others develop multiple stones [3]. Importantly, many gallstones never cause symptoms and are discovered incidentally.

Several factors are associated with an increased likelihood of gallstone formation, including:

• increasing age
• female sex
• obesity
• pregnancy
• rapid weight loss
• certain blood, metabolic and gastrointestinal conditions
• some medications

The presence of gallstones becomes particularly important when they interfere with the normal flow of bile. A stone obstructing the outlet of the gallbladder can produce biliary pain, while persistent obstruction can lead to inflammation of the gallbladder [4]. Stones that enter the bile ducts can cause further complications, including bile duct obstruction, infection or pancreatitis.

For this reason, doctors do not determine treatment simply by asking whether stones are present. Whether they are causing symptoms or complications is usually much more important.

 

Understanding Gallbladder Polyps

Gallbladder polyps require a different type of assessment because they arise from the gallbladder wall instead of forming within bile. They appear on imaging as projections extending from the inner surface of the gallbladder into its cavity.

Importantly, most gallbladder polyps detected on ultrasound are benign [5]. Many are cholesterol polyps, sometimes called pseudopolyps, which are related to cholesterol deposits within the gallbladder wall. Other benign lesions include inflammatory polyps, while true neoplastic polyps such as adenomas are less common.

The reason polyps are assessed carefully is that some neoplastic lesions, including gallbladder cancer, can have a polypoid appearance. A diagnosis of a gallbladder polyp, therefore, does not mean that cancer is present. Instead, the purpose of assessment is to identify the relatively small group of lesions with features that warrant closer surveillance, further investigation or surgery.

Doctors may consider factors such as:

• polyp size
• shape and appearance on ultrasound
• growth on subsequent imaging
• associated changes in the gallbladder wall
• relevant individual risk factors

Most gallbladder polyps are asymptomatic and discovered incidentally. Depending on their characteristics and the patient's risk profile, management can range from no further follow-up to repeat ultrasound surveillance or consideration of gallbladder removal.

Gallstones vs Gallbladder Polyps: Key Differences

The distinction between gallstones and gallbladder polyps becomes particularly clear on ultrasound. Stones usually lie freely within the gallbladder and move with changes in body position, whereas polyps remain attached to the gallbladder wall. Their clinical significance is also assessed differently.

Feature	Gallstones	Gallbladder Polyps
Origin	Form from the components of bile	Arise from the gallbladder wall
Position	Lie within the gallbladder cavity	Project from and remain attached to the gallbladder wall
Movement on Ultrasound	Usually move when the patient's position changes	Usually remain fixed to the wall
Acoustic Shadowing	Typically produce posterior acoustic shadowing	Typically do not produce posterior acoustic shadowing
Symptoms	Often asymptomatic but can cause biliary pain and complications	Usually asymptomatic
Main Clinical Concern	Symptoms and stone-related complications	Size, growth, morphology and features associated with malignancy risk
Monitoring	Routine surveillance is generally unnecessary for uncomplicated asymptomatic gallstones	Selected polyps may require follow-up ultrasound
Surgery	Usually considered when stones cause symptoms or complications	May be considered for polyps with characteristics that warrant removal

When Gallstones Begin to Affect Your Health

Many gallstones remain silent, meaning they cause no symptoms and may never create a health problem. They are often discovered incidentally during an ultrasound or another abdominal investigation. The situation changes when a stone interferes with the normal drainage of bile.

A common presentation is biliary colic, which occurs when a gallstone temporarily obstructs the outlet of the gallbladder. This typically causes steady pain in the upper abdomen, often towards the right side or centre. The pain may become intense and can last from around 30 minutes to several hours before settling as the obstruction resolves.

More persistent obstruction or movement of stones into the bile ducts can lead to complications, including:

• Acute cholecystitis — inflammation of the gallbladder, usually causing persistent upper-right abdominal pain and tenderness, sometimes accompanied by fever [6].
• Choledocholithiasis — a gallstone enters and obstructs the common bile duct, potentially disrupting the normal flow of bile [7].
• Jaundice or cholangitis — bile duct obstruction can cause yellowing of the skin and eyes; if infection develops within an obstructed biliary system, cholangitis can occur and requires urgent medical treatment [8].
• Gallstone pancreatitis — a stone passing through the bile duct can obstruct the region where the pancreatic duct drains, triggering inflammation of the pancreas [9].

This distinction is important when considering treatment. Having gallstones is not the same as having symptomatic gallstone disease. An incidental stone that has never caused symptoms is approached differently from gallstones causing recurrent pain, inflammation or other complications.

Why the Size and Appearance of a Gallbladder Polyp Matter

With gallbladder polyps, doctors are usually less concerned with symptoms alone and more interested in what the lesion looks like and whether it has features associated with a greater likelihood of neoplasia or malignancy.

One of the most important characteristics is polyp size. Larger polyps warrant greater attention, and a size of around 10 mm has traditionally been an important threshold at which cholecystectomy may be considered or recommended in several clinical guidelines [10]. However, size should not be interpreted in isolation, and recommendations differ between guidelines, particularly for polyps below this threshold.

Assessment may also take into account:

• whether the polyp has increased in size on follow-up imaging
• whether it has a sessile appearance, meaning it has a broad base instead of being attached by a narrow stalk
• associated focal gallbladder wall thickening
• other imaging characteristics that make the nature of the lesion uncertain
• individual factors associated with a higher risk of malignancy
• symptoms potentially attributable to the gallbladder after other causes have been considered

This is why two patients with gallbladder polyps may receive different recommendations even when neither has symptoms. A small polyp with reassuring features may require little or no surveillance, while a larger, growing or otherwise concerning lesion may warrant closer investigation or consideration of gallbladder removal.

How Gallstones and Gallbladder Polyps Are Assessed

Abdominal ultrasound is usually the primary imaging test for suspected gallstones and gallbladder polyps. It allows the gallbladder, its contents and its wall to be examined without radiation and can often distinguish between the two findings.

Gallstones typically appear as bright, echogenic structures within the gallbladder. They usually move when the patient’s position changes and commonly produce posterior acoustic shadowing, where the stone blocks the ultrasound beam and creates a shadow behind it. Ultrasound can also identify findings that may accompany acute gallbladder inflammation, such as wall thickening or fluid around the gallbladder.

Gallbladder polyps behave differently on ultrasound. They:

• arise from and remain attached to the gallbladder wall
• typically do not move when the patient's position changes
• generally do not produce posterior acoustic shadowing
• are assessed according to their size, shape and relationship with the gallbladder wall

Accurate measurement is particularly important for polyps because size can influence decisions about surveillance and surgery.

Sometimes an ultrasound cannot confidently determine the nature of a gallbladder lesion. In selected cases, additional or more specialised imaging may be considered to clarify an uncertain finding or provide further characterisation before management is decided.

Monitoring Versus Treatment

Not every gallstone or gallbladder polyp requires treatment simply because it has been detected. The appropriate approach depends on the type of finding, whether it is causing symptoms, its imaging characteristics and the likelihood of future complications.

For gallstones, symptoms are an important part of the decision. Gallstones discovered incidentally in someone who has never experienced biliary symptoms can often be managed without surgery. Once stones begin causing recurrent pain or complications, however, treatment becomes more likely to be recommended.

Management of gallstones may therefore include:

• Observation for asymptomatic gallstones in most patients
• Cholecystectomy for recurrent or troublesome gallstone symptoms
• More urgent assessment and treatment when complications such as acute cholecystitis, bile duct obstruction, cholangitis or gallstone pancreatitis occur
• Additional procedures, such as endoscopic removal of common bile duct stones, when stones have migrated outside the gallbladder

For gallbladder polyps, management is guided less by symptoms alone and more by the characteristics of the lesion. The size and morphology of the polyp, changes seen on follow-up imaging and relevant patient-specific risk factors all help determine whether observation or surgery is appropriate.

Depending on these findings, management may involve:

• No further follow-up for some small polyps with reassuring features
• Ultrasound surveillance for selected polyps to monitor their size and appearance over time
• Further assessment when imaging is inconclusive or the lesion has concerning characteristics
• Cholecystectomy when the size, growth, morphology or overall risk profile makes surgical removal appropriate

The important distinction is that gallstones are generally treated because of the symptoms or complications they cause, while gallbladder polyps are managed primarily according to their characteristics and potential clinical risk. In both cases, the decision should be individualised instead of being based on the ultrasound finding alone.

When Gallbladder Removal May Be Recommended

Although gallstones and gallbladder polyps are different conditions, both may be treated with cholecystectomy when there is a clear clinical reason to remove the gallbladder.

Gallbladder removal may be recommended for:

• Recurrent symptomatic gallstones causing episodes of biliary pain [11]
• Acute or recurrent cholecystitis caused by gallstones
• Gallstone-related complications, such as bile duct stones or gallstone pancreatitis
• Gallbladder polyps with concerning characteristics, including size, growth or morphology associated with a higher risk of malignancy [12]
• Selected symptomatic gallbladder polyps, where symptoms are considered likely to originate from the gallbladder and other causes have been appropriately assessed

Cholecystectomy removes the entire gallbladder together with the stones or polyp, instead of removing the individual finding alone. When surgery is appropriate, a laparoscopic approach is generally preferred where it can be performed safely.

Symptoms That Should Prompt Medical Attention

An incidental gallstone or gallbladder polyp may cause no immediate problems. However, certain symptoms should not be ignored, particularly because they may indicate gallstone obstruction, inflammation or infection.

Seek prompt medical assessment if you develop:

• severe or persistent upper abdominal pain
• abdominal pain accompanied by fever or chills
• yellowing of the skin or eyes (jaundice)
• persistent vomiting
• marked abdominal tenderness
• abdominal symptoms accompanied by feeling significantly unwell

These symptoms can occur with complications such as acute cholecystitis, bile duct obstruction, cholangitis or pancreatitis and may require urgent assessment. An incidental gallbladder polyp alone would not usually be expected to cause an acute episode of severe illness, so other biliary or abdominal causes need to be considered.

Key Takeaway

Gallstones and gallbladder polyps may both be identified during an ultrasound, but the similarity largely ends there. Gallstones form within bile and become clinically important mainly when they cause symptoms, obstruction or complications. Gallbladder polyps arise from the gallbladder wall and are assessed principally according to their size, morphology, growth and other features that help determine their level of risk.

Neither finding automatically means that surgery is necessary. Many people with asymptomatic gallstones require no treatment, while many small gallbladder polyps can be managed conservatively, depending on their characteristics and individual risk factors. An ultrasound result, therefore, needs to be considered alongside your symptoms, medical history, previous imaging and the specific features reported on the scan.

If an ultrasound has identified gallstones or a gallbladder polyp and you are unsure what the finding means for your health, consider scheduling a consultation with a specialist at Tan Siong San Surgery for an individual assessment and discussion of the appropriate next steps.

Frequently Asked Questions (FAQs) 

References

1. Jones, M. W., Weir, C. B., & Marietta, M. (2026). Gallstones(Cholelithiasis). In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK459370/ 
2. Andrén-Sandberg, Å. (2012). Diagnosis and management of gallbladder polyps. North American Journal of Medical Sciences, 4(5), 203–211. https://doi.org/10.4103/1947-2714.95897 
3. Definition & facts for gallstones—Niddk. National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved August 27, 2026, from https://www.niddk.nih.gov/health-information/digestive-diseases/gallstones/definition-facts 
4. Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary Dyskinesia. Pubmed. Ncbi. Nlm. Nih. Gov. Retrieved August 27, 2026, from https://pubmed.ncbi.nlm.nih.gov/29132521/ 
5. Cocco, G., Basilico, R., Delli Pizzi, A., Cocco, N., Boccatonda, A., D’Ardes, D., Fabiani, S., Anzoletti, N., D’Alessandro, P., Vallone, G., Cipollone, F., & Schiavone, C. (2021). Gallbladder polyps ultrasound: What the sonographer needs to know. Journal of Ultrasound, 24(2), 131–142. https://doi.org/10.1007/s40477-021-00563-1 
6. Jones, M. W., Santos, G., Patel, P. J., & O’Rourke, M. C. (2026). Acute cholecystitis. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK459171/ 
7. McNicoll, C. F., Pastorino, A., Farooq, U., Froehlich, M. J., & St Hill, C. R. (2026). Choledocholithiasis. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK441961/ 
8. Virgile, J., & Marathi, R. (2026). Cholangitis. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK558946/ 
9. Isogai, M. (2024). Pathophysiology of severe gallstone pancreatitis: A new paradigm. World Journal of Gastroenterology, 30(7), 614–623. https://doi.org/10.3748/wjg.v30.i7.614 
10. Gurusamy, K. S., Abu‐Amara, M., Farouk, M., & Davidson, B. R. (2009). Cholecystectomy for gallbladder polyp. The Cochrane Database of Systematic Reviews, 2009(1), CD007052. https://doi.org/10.1002/14651858.CD007052.pub2  
11. Shabanzadeh, D. M. (2023). The symptomatic outcomes of cholecystectomy for gallstones. Journal of Clinical Medicine, 12(5), 1897. https://doi.org/10.3390/jcm12051897 
12. Van Dooren, M., De Savornin Lohman, E. A. J., Van Der Bilt, J., De Boer, M. T., Boerma, D., Bos, P., Braat, A. E., De Castro, S. M. M., Corten, B. J. G. A., Daams, F., Erdmann, J. I., Ferenschild, F., Fortuin, A. S., Van Geloven, N., Van Der Hoeven, E., Klicks, R., Kruyt, F. M., Langenhoff, B. S., Liem, M. S. L., … De Reuver, P. (2025). Revised guidelines for the treatment and follow‐up of gallbladder polyps do not reduce unwarranted cholecystectomies: Results of the polyp study. United European Gastroenterology Journal, 13(7), 1133–1140. https://doi.org/10.1002/ueg2.70057